Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6323304626624516,-2.0663396832496983,0.0,0.019313704275887054,0.017,20/29,22.74%,GRIK2;GRID2;GABRG3;GRIA2;GABRB1;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GLRA3;GLRA2;GABRB2;GABRA1;GABRE;GRIA4;GRIK5;GABRB3;CHRNB1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.7990095022032405,-2.034853548517523,0.0,0.012706384392030957,0.023,9/12,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE4B;PDE2A
prerank,amino acid:sodium symporter activity (GO:0005283),-0.8101523684900656,-2.0123623844885263,0.0,0.014231150519074675,0.038,7/11,14.33%,SLC1A3;SLC6A13;SLC6A12;SLC1A2;SLC1A1;SLC6A1;SLC6A15
prerank,cAMP binding (GO:0030552),-0.767131870594936,-1.9001101349026637,0.0025380710659898475,0.05692460207629869,0.178,7/11,9.95%,RAPGEF2;PDE4D;PDE4A;PDE10A;PDE4B;CNBD2;PDE2A
prerank,phosphatidate phosphatase activity (GO:0008195),0.8649702190680186,1.8669569690701633,0.0,1.0,0.566,1/13,0.01%,PLPPR2
prerank,lipid phosphatase activity (GO:0042577),0.8477726183438675,1.8483960111927675,0.0016051364365971107,0.6844078889902312,0.66,1/14,0.01%,PLPPR2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.7386303572161149,-1.8425920202612176,0.0,0.10022796008434019,0.356,4/11,10.65%,SASH1;DAB2IP;ROR2;TRAF6
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.71675219991424,-1.8415617164547802,0.0,0.08386213698740433,0.357,10/13,19.25%,GABRG3;GLRA1;GABRG2;GABRG1;GABRA3;GLRA3;GLRA2;GABRA1;GLRB;GABRE
prerank,C-C chemokine receptor activity (GO:0016493),0.7730677087870963,1.8351434099335964,0.0028129395218002813,0.5503076494928709,0.717,8/21,6.17%,CCR4;CXCR4;ACKR2;ACKR4;CCR10;ACKR3;CCRL2;GPR75
prerank,tropomyosin binding (GO:0005523),0.8072606824578215,1.823043525136502,0.0061162079510703364,0.47754585287671064,0.769,6/16,5.09%,CALD1;NEBL;TMOD3;S100A6;TMOD2;LMOD3
prerank,platelet-derived growth factor binding (GO:0048407),-0.7669249867701751,-1.8172874097292417,0.0025974025974025974,0.09526157898482637,0.44,6/11,3.97%,PDGFRB;COL1A2;COL1A1;COL5A1;PDGFRA;COL4A1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7353589170606364,-1.8066210926447503,0.0024271844660194173,0.09377311681318848,0.476,4/11,4.78%,KCNK2;KCNT2;KCND2;PKD2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6056974284052549,-1.7938789466766716,0.012195121951219513,0.09555201062807281,0.519,13/19,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,androgen receptor binding (GO:0050681),0.7255123373546557,1.7667247341391612,0.007072135785007072,0.7001025836869592,0.926,14/25,20.23%,PRKCB;DAXX;DDX5;EP300;TGFB1I1;KDM3A;KDM4C;SMARCA4;FOXP1;KDM1A;PRPF6;PARK7;ZBTB7A;PRMT2
prerank,chemokine receptor activity (GO:0004950),0.7359188831748816,1.7604147648289525,0.008253094910591471,0.6195099953075581,0.934,8/24,6.17%,CCR4;CXCR4;ACKR2;ACKR4;CCR10;ACKR3;CCRL2;GPR75
prerank,retinoic acid binding (GO:0001972),-0.708162778403227,-1.758398134627241,0.002531645569620253,0.12065982618672598,0.637,2/12,5.05%,NR2F2;CYP26B1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.670364919591093,-1.7383755424092984,0.014124293785310734,0.13223880774542765,0.706,5/14,9.99%,SLC7A11;SLC1A3;SLC1A2;SLC1A1;SLC17A6
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7355358650209999,1.717925248220117,0.021439509954058193,0.7826061596062877,0.981,6/18,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;S100A11;ANXA2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.7116974275783082,-1.7159122500604558,0.015544041450777202,0.1509518465773278,0.776,4/10,8.59%,SLC24A3;SLC8A1;SLC8A3;SLC24A2
prerank,disordered domain specific binding (GO:0097718),0.7116196877116261,1.707365741715022,0.014184397163120567,0.7522030100694522,0.987,2/23,1.24%,FN1;NCOA3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6805208161208904,-1.7067287660613228,0.0028089887640449437,0.15224203330021094,0.796,9/12,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,C-C chemokine binding (GO:0019957),0.725178825718453,1.698435940854027,0.018439716312056736,0.7190642471813184,0.989,7/22,5.94%,CCR4;CXCR4;ACKR2;ACKR4;CCR10;ACKR3;CCRL2
prerank,glutamate receptor activity (GO:0008066),-0.5716584211163368,-1.6926462682152406,0.027692307692307693,0.16031826707202487,0.842,13/19,20.40%,GRIK2;GRID2;GRM3;GRM7;GRIA2;GRM8;GRM5;GRIK3;GRIK1;GRIK4;GRM1;GRIA4;GRIK5
prerank,potassium:proton antiporter activity (GO:0015386),0.8442794206229292,1.6909441683337605,0.008460236886632826,0.6850038900546639,0.994,2/10,0.16%,SLC9A2;SLC9A4
prerank,5'-nucleotidase activity (GO:0008253),0.7726664589389982,1.6886147951978823,0.0224,0.6341090112797735,0.994,4/13,6.84%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,ligand-gated channel activity (GO:0022834),-0.5123834877095701,-1.6870826837557162,0.011673151750972763,0.15688149262694223,0.858,16/29,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,serine-type peptidase activity (GO:0008236),0.5720006181445415,1.6865208905700597,0.004479283314669653,0.5904549434164633,0.994,14/96,10.78%,DPP4;KLK11;KLK10;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;NAALAD2;PREP;KLK1;HP;HPR
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.8172790076728296,1.686265705974717,0.016666666666666666,0.5457994363131876,0.994,3/10,2.15%,CXADR;DSG2;CD200
prerank,ligand-gated ion channel activity (GO:0015276),-0.5086452921767226,-1.6762374030206166,0.00796812749003984,0.16086282640311192,0.884,16/30,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,GABA-A receptor activity (GO:0004890),-0.5898512956508435,-1.6672619257225076,0.012012012012012012,0.16156541471655364,0.894,9/18,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,death domain binding (GO:0070513),0.8089028827457055,1.6670110305934356,0.021996615905245348,0.593588679171913,0.994,1/11,0.02%,DAPL1
prerank,nucleotidase activity (GO:0008252),0.7379945123330542,1.657506936890987,0.032208588957055216,0.595206396346802,0.994,4/15,6.84%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5271359393217011,-1.657117856575435,0.007722007722007722,0.16619950784776494,0.915,13/28,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,sodium:proton antiporter activity (GO:0015385),0.8094148705201512,1.646141828978533,0.011627906976744186,0.6087902539403308,0.998,2/11,0.16%,SLC9A2;SLC9A4
prerank,cytokine activity (GO:0005125),0.5409637251780792,1.6430802440442118,0.004362050163576881,0.58478222086692,0.998,19/131,7.95%,WNT16;TNFRSF11B;CRLF1;WNT1;CCL5;WNT10A;IL15;GDF15;WNT11;IL16;WNT6;BMP5;CLCF1;EPO;TIMP1;BMP4;TGFB2;SLURP1;WNT5B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.6325631147611728,-1.6370658501508006,0.019704433497536946,0.18580746523588848,0.947,6/12,9.34%,IGF1;PIK3R1;INSR;GNAS;IGF2;ARRB1
prerank,cell adhesion mediator activity (GO:0098631),-0.5359316750613159,-1.6339772234068888,0.006309148264984227,0.18159964573090645,0.95,11/24,10.61%,CD47;ESAM;PALLD;EMB;LRRC4C;NEXN;DSCAML1;CNTN6;BSG;NTNG1;ROBO4
prerank,serine-type endopeptidase activity (GO:0004252),0.5576355930685932,1.632349562801318,0.006857142857142857,0.596773658405125,0.999,10/80,10.78%,DPP4;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;KLK1;HP;HPR
prerank,sterol transfer activity (GO:0120015),-0.5813035879861455,-1.6266444012537293,0.024024024024024024,0.1840368512704827,0.954,5/17,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7807273390413033,1.6217009444905677,0.025597269624573378,0.6102214407068961,1.0,3/10,6.10%,DPP4;DPP7;NAALAD2
prerank,metal ion:proton antiporter activity (GO:0051139),0.7748353565843151,1.620936774625477,0.0224,0.5832367083027783,1.0,2/13,0.16%,SLC9A2;SLC9A4
prerank,cholesterol transfer activity (GO:0120020),-0.5906655539697487,-1.620655908956763,0.01764705882352941,0.1840346510307611,0.958,5/16,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6155068499002888,-1.6147174538332663,0.018518518518518517,0.18416523047510608,0.962,5/13,3.60%,PDGFRB;PDGFD;PTPRJ;IL1R1;PDGFRA
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7845238341048368,1.6076535792831481,0.019704433497536946,0.6125093478840627,1.0,2/12,0.16%,SLC9A2;SLC9A4
prerank,frizzled binding (GO:0005109),0.6201236860551504,1.6002953741635506,0.035961272475795295,0.6148744314730814,1.0,8/34,7.95%,WNT16;WNT1;WNT10A;WNT11;RNF43;WNT6;DVL3;WNT5B
prerank,protein kinase C binding (GO:0005080),0.5921624979710503,1.598063496862613,0.028871391076115485,0.5969512110571702,1.0,10/43,10.15%,PRKCB;PDLIM5;GRK5;HDAC5;CAVIN2;HSPB1;ADCY6;PARD6B;DACT2;NELL2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.42395099762689387,-1.5744273342860609,0.005405405405405406,0.2411248211461075,0.985,28/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;ACVRL1;TIE1;PDGFRA;KDR;BMPR1B;ACVR1B;EPHB2;EPHB4;ROR2;NTRK2;ACVR2A;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6591367461113655,-1.5635718486058596,0.045112781954887216,0.25071221171604124,0.989,6/10,19.25%,GABRG3;GABRG2;GABRG1;GABRA3;GABRA1;GABRE
prerank,receptor antagonist activity (GO:0048019),0.6717654465774079,1.5373459800098443,0.04084720121028744,0.85911070100207,1.0,4/17,6.76%,CCL5;ADH7;IGSF1;PXDN
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.6239872943357221,1.5283493540194855,0.037921348314606744,0.8752871632258811,1.0,2/27,0.16%,SLC9A2;SLC9A4
prerank,potassium ion antiporter activity (GO:0022821),0.6968668540930485,1.5207315012116134,0.04251968503937008,0.8828456792891739,1.0,2/15,0.16%,SLC9A2;SLC9A4
prerank,glycine binding (GO:0016594),-0.6214248546305967,-1.5204082585286554,0.058673469387755105,0.32344590177006804,1.0,10/11,35.08%,GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;GRIN3A;GRIN1;GLDC;GNMT
prerank,exopeptidase activity (GO:0008238),0.5536870715552061,1.5169984153887548,0.05148005148005148,0.8683588348027967,1.0,6/50,7.06%,DPP4;CPB1;DPP7;NAALAD2;CTSZ;CPE
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5854384149134969,1.5145296028936153,0.05858854860186418,0.8501529469086616,1.0,21/37,21.35%,QARS1;EPRS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;HARS2;TARS1;SARS1;SARS2;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,carboxypeptidase activity (GO:0004180),0.584426285249347,1.5143470883449806,0.053735255570117955,0.8215223867444925,1.0,9/35,7.94%,CPB1;CPA4;CPA3;MINDY2;AGTPBP1;NAALAD2;CTSZ;CPE;AGBL1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5397627279525004,-1.509249978007961,0.05847953216374269,0.33559914213500436,1.0,8/17,11.93%,GRIK2;GRIN2A;GRIA3;GRIA2;GRIN2B;GRIK3;GRIK1;GRIK4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7308713409979628,1.508749800377135,0.03980099502487562,0.8234416928542845,1.0,6/10,17.90%,ECHDC1;EHHADH;HADHA;AUH;HADHB;ECHS1
prerank,ankyrin binding (GO:0030506),0.6519242734353122,1.5073854867578766,0.07309941520467836,0.8033197142649514,1.0,1/19,0.06%,CDH1
prerank,G protein-coupled receptor binding (GO:0001664),0.49566273893527124,1.5058160836993206,0.01737242128121607,0.7853866110006276,1.0,21/132,11.35%,WNT16;ITGB4;AGTR1;WNT1;CCL5;WNT10A;PENK;WNT11;ARHGEF12;RNF43;HOMER2;HOMER3;WNT6;CCRL2;DVL3;WNT5B;USP20;GRK2;GNAO1;GNAQ;GNA13
prerank,protease binding (GO:0002020),0.5007367643326301,1.494302262996775,0.026785714285714284,0.8180867135935481,1.0,14/99,10.93%,FN1;DPP4;LDLR;TIMP4;SERPINC1;TIMP1;TIMP2;LCOR;ANXA2;DVL3;ADAMTSL4;POLG;CARD16;ATP9A
prerank,GABA receptor activity (GO:0016917),-0.505238485269037,-1.490952369414912,0.041666666666666664,0.36590756653508577,1.0,10/21,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GPR156;GABRB2;GABRA1;GABRE;GABRB3
prerank,protein phosphatase 2A binding (GO:0051721),-0.48474187452548867,-1.4903298958324542,0.037383177570093455,0.3547622522255044,1.0,13/23,24.42%,CTTNBP2NL;MFHAS1;FOXO1;DAB2IP;TP53;PPME1;BOD1L1;MASTL;STRN;BOD1;SPHK1;ADCY8;GRIN3A
prerank,ATP hydrolysis activity (GO:0140603),0.5588272551171252,1.4896028250027233,0.054376657824933686,0.8172226359956777,1.0,14/41,20.11%,CFTR;CLU;ABCD1;SHOC1;TOR1A;VPS4B;CHD3;DHX9;HSP90AA1;MYO1E;KIF20B;ABCB6;MYO18A;ABCA4
prerank,NAD binding (GO:0051287),-0.46879143608813917,-1.4870324253084792,0.06028368794326241,0.3493408615515712,1.0,11/26,28.69%,ALDH1A1;ZC3HAV1;ME1;HPGD;SIRT2;ALDH2;SORD;CRYZ;BDH2;NNT;SIRT6
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6778252692971792,1.4849572368660746,0.07473841554559044,0.816180886235997,1.0,4/15,5.94%,CCR4;ACKR2;ACKR4;CCRL2
prerank,chemorepellent activity (GO:0045499),0.6152862162761752,1.481641654519924,0.06851311953352769,0.809016259683663,1.0,3/25,2.81%,DPP4;SEMA3D;SEMA3B
prerank,Wnt-activated receptor activity (GO:0042813),-0.5572418973808958,-1.4741576221117354,0.07988980716253444,0.36643573053147344,1.0,7/15,11.00%,ROR1;FZD6;FZD4;LRP5;TSPAN12;RYK;FZD1
prerank,receptor ligand activity (GO:0048018),0.4685547731884898,1.4713806561884215,0.007150153217568948,0.8363613135257785,1.0,31/245,8.78%,DPP4;WNT16;SEMA3D;TNFRSF11B;CRLF1;WNT1;CCL5;EDA;WNT10A;NBL1;IL15;GDF15;WNT11;SEMA3B;IL16;NGF;TNFSF13;GDNF;WNT6;BMP5;CLCF1;EPO;TIMP1;BMP4;OSGIN2;TGFB2;SLURP1;WNT5B;FGF22;LGALS3;VEGFB
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.559316335794234,-1.4710015282351836,0.06,0.36178252960210144,1.0,5/15,9.99%,SLC1A3;SLC1A5;SLC1A2;SLC1A1;SLC17A6
prerank,potassium channel activity (GO:0005267),-0.35273902865187295,-1.4677724887106003,0.0,0.35741134085026716,1.0,28/89,23.54%,KCNK2;KCNT2;GRIK2;KCND2;KCNK5;KCNN2;ABCC9;PKD2;KCNQ4;GRIK3;HCN2;GRIK1;GRIK4;CCDC51;KCNC1;TMEM38B;KCNMB4;KCNMA1;KCNK13;KCNH5;KCNQ3;HCN1;KCNK3;GRIK5;KCNK12;KCND1;KCNC3;KCNB2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6106244229647358,-1.463721907731636,0.058823529411764705,0.3551509181010253,1.0,3/10,5.48%,MECOM;SETD5;PRDM16
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.6960803152355077,1.4617742692326101,0.09168081494057725,0.8612999592979577,1.0,1/11,0.43%,NUDT4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6840387070245453,1.4566226329022756,0.08552631578947369,0.8658316318087871,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5400985072748465,-1.4532763317738333,0.0653950953678474,0.36710559706347734,1.0,6/15,16.26%,HS6ST2;HS3ST3A1;NDST3;HS6ST3;HS3ST3B1;HS3ST1
prerank,pre-mRNA binding (GO:0036002),0.5737994310460635,1.451972503947569,0.08413793103448276,0.8667593813289564,1.0,4/28,5.55%,CELF2;DDX5;CELF1;TARBP2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5370393625496102,1.4478476003472731,0.06439393939393939,0.866430490497669,1.0,12/46,12.36%,B3GALT1;OGT;HEXA;B4GAT1;MGAT3;GCNT2;LARGE1;MGAT1;EXT1;HEXB;MGAT4C;PIGA
prerank,growth factor receptor binding (GO:0070851),-0.35505109437073806,-1.4388659382907165,0.007692307692307693,0.38771414241550467,1.0,19/95,12.85%,PDGFRB;PDGFD;HIP1;PTPRJ;IL1R1;TGFA;VEGFC;GLMN;PDGFRA;KL;FGF2;IL6R;JAK2;ERBB4;PLSCR1;LINGO1;GRB2;IL6ST;CNOT9
prerank,chloride transmembrane transporter activity (GO:0015108),0.6293626901343374,1.434791119158114,0.09047619047619047,0.9107463884593207,1.0,1/16,0.12%,CFTR
prerank,neuropeptide receptor activity (GO:0008188),0.5624312601518574,1.4324423028563118,0.08356545961002786,0.9010011440336851,1.0,2/29,1.37%,SORCS2;GAL
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5232136626182655,1.4290424810004378,0.06801007556675064,0.8968009955880705,1.0,13/48,13.38%,TRPM3;ATP6V1B1;NALCN;TRPM8;CALHM5;TMEM165;TRPM6;AQP1;TRPM4;PKD2L1;SLC41A1;SLC12A4;TRPM2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6020940789670217,-1.425587485420599,0.09278350515463918,0.4068515599169437,1.0,3/10,4.94%,GNAS;SHANK3;SHISA6
prerank,estrogen receptor binding (GO:0030331),-0.43960178641985675,-1.4255602244733425,0.04710144927536232,0.3962251907679211,1.0,8/32,12.06%,LEF1;TACC1;ESR1;NCOA1;NSD1;RERG;PADI2;CCDC62
prerank,MAP kinase kinase activity (GO:0004708),-0.5354960733899584,-1.4249506501984632,0.0935672514619883,0.3873687894038238,1.0,8/15,21.53%,PAK3;MAPK10;MAP2K6;LRRK2;MAP2K4;MAP2K1;MAP3K9;MAPK14
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5110099198935681,1.4203563588232604,0.08384710234278668,0.9221902395853859,1.0,7/55,7.33%,SLC7A14;SLC36A3;SLC16A5;SLC16A11;SLC16A2;SLC36A4;SLC3A1
prerank,chemokine binding (GO:0019956),0.5718052633347641,1.4192169702690356,0.07905138339920949,0.9079514766354281,1.0,7/30,5.94%,CCR4;CXCR4;ACKR2;ACKR4;CCR10;ACKR3;CCRL2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6593421668448874,1.4138321843963542,0.1136,0.9149250382727699,1.0,1/12,1.14%,OPN1SW
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5017778666254324,-1.4130067920067801,0.08115942028985507,0.40446962796712943,1.0,6/18,8.35%,LTBP1;ENG;ACVRL1;BMPR1B;ACVR1B;ACVR2A
prerank,nucleotide diphosphatase activity (GO:0004551),0.6483729591188123,1.4107387709434585,0.11661341853035144,0.9110538493258932,1.0,2/14,2.11%,NUDT4;FHIT
prerank,sulfotransferase activity (GO:0008146),0.5350441184325188,1.410598530261646,0.10340136054421768,0.8931096222669241,1.0,5/33,5.34%,UST;SULT1A1;CHST12;SULT2B1;CHST11
prerank,chloride channel regulator activity (GO:0017081),0.633522825382141,1.402097764563135,0.121875,0.9176032388006037,1.0,2/14,3.69%,CFTR;SGK3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.6181040439761062,1.4010822973783847,0.1171875,0.9036817446563579,1.0,1/15,0.12%,CFTR
prerank,sialyltransferase activity (GO:0008373),-0.4704166910110634,-1.4006562876342714,0.09253731343283582,0.4238106044826872,1.0,7/20,8.01%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST3GAL3;ST6GALNAC5;ST8SIA6
prerank,chloride channel inhibitor activity (GO:0019869),0.6774468650466213,1.3968616430050835,0.136986301369863,0.9073352102059283,1.0,1/10,0.12%,CFTR
prerank,R-SMAD binding (GO:0070412),0.6077833173557831,1.3966302611729193,0.09370424597364568,0.8913589504199799,1.0,7/18,11.45%,SMAD6;DDX5;TRIM33;FOS;PPM1A;JUN;LDLRAD4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4396061646160271,-1.39554578513524,0.09523809523809523,0.4253371415343849,1.0,10/26,10.11%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;SLC6A6;SLC16A6;SLC16A1;SLC16A4;SLC6A1;SLC16A7
prerank,insulin-like growth factor I binding (GO:0031994),0.6518622888981351,1.3945409877501957,0.10333863275039745,0.8838475044402146,1.0,2/13,0.78%,ITGB4;IGFBP6
prerank,phosphatase activity (GO:0016791),0.48942359808234176,1.393297646449694,0.08056872037914692,0.873593075351827,1.0,4/73,5.44%,PLPPR2;ATP1A2;DUSP10;DUSP12
prerank,ferrous iron binding (GO:0008198),0.5993516936810748,1.392650806595392,0.1099554234769688,0.8608312993130811,1.0,4/21,11.32%,EGLN3;EGLN2;HEPH;CDO1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5154360590601265,1.392529038564443,0.0901015228426396,0.8463215114944515,1.0,6/47,7.33%,SLC7A14;SLC36A3;SLC66A1;SLC16A2;SLC36A4;SLC3A1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.48940596024217353,1.3899082582630173,0.07228915662650602,0.8435641502480816,1.0,12/70,12.10%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;GCNT2;LARGE1;CHPF;EXT1;HEXB;CHPF2;MGAT4C
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5811059453776066,-1.3889698931463417,0.10353535353535354,0.4310241983626055,1.0,7/10,32.97%,ADARB2;GDA;APOBEC1;CDA;ADA;DCTD;LACC1
prerank,O-acyltransferase activity (GO:0008374),0.5475266334762952,1.3883306020164414,0.09778357235984354,0.8361524537849214,1.0,10/30,12.85%,MBOAT2;SOAT1;DGAT1;MOGAT3;MOGAT1;SOAT2;GPAM;MBOAT7;LPCAT2;LPCAT3
prerank,NF-kappaB binding (GO:0051059),0.5702615666927654,1.3879955627047018,0.10267229254571027,0.823640359875762,1.0,9/24,14.35%,EP300;ANXA4;MTDH;NFKBIA;COMMD7;FOXP3;HDAC3;COMMD6;GSK3B
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6307091712443442,1.3867715288071034,0.11916264090177134,0.8155932598937812,1.0,5/14,11.05%,MINDY2;MINDY3;OTUD7B;DESI2;MINDY4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.48262703580739,-1.3791611020486496,0.11676646706586827,0.4429445599061992,1.0,6/18,5.66%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2;ALDH6A1
prerank,potassium ion leak channel activity (GO:0022841),-0.5131621105005688,-1.3785231994790703,0.10144927536231885,0.43459222989917085,1.0,8/15,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNK6;KCNK4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3701498821913957,-1.3768953463264186,0.047619047619047616,0.4288349487160918,1.0,25/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;TIE1;PDGFRA;KDR;IGF2R;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,neuropeptide binding (GO:0042923),-0.4933434416700668,-1.3707009407450752,0.12602739726027398,0.4326875338671852,1.0,12/18,44.30%,GPR37;SORL1;OPRM1;OPRK1;NMUR2;GPR149;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,insulin-like growth factor binding (GO:0005520),0.6178717750476044,1.3703796393721237,0.11674347158218126,0.8745995189870249,1.0,2/15,0.78%,ITGB4;IGFBP6
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.653964808234712,1.3620647282505076,0.13793103448275862,0.8974388514651088,1.0,7/10,25.17%,GFUS;DSE;GALE;FUOM;GNE;RPE;GLCE
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6499317061978067,1.3618172971654887,0.1309328968903437,0.8843786627962484,1.0,5/11,19.69%,MAP3K5;MAP3K4;MAP3K13;MAP3K6;MAP3K1
prerank,Hsp70 protein binding (GO:0030544),-0.4149212974970991,-1.3610824108447195,0.08487084870848709,0.44461756718448325,1.0,7/31,8.26%,PACRG;SACS;TSC1;DNAJC18;GPR37;DNAJA1;DNAJB12
prerank,proton transmembrane transporter activity (GO:0015078),0.5209295169040343,1.3602915144500005,0.11864406779661017,0.8775886442593059,1.0,18/39,24.95%,ATP6V1B1;COX5A;CTNS;COX8A;UQCRC1;COX7A2L;CLCN4;COX5B;UQCR11;SLC9A1;SLC11A2;UQCRH;ATP6V1B2;COX4I1;COX10;SLC4A11;UQCRFS1;CYB5A
prerank,kinase activator activity (GO:0019209),0.5394642174027068,1.3589064330099239,0.11307901907356949,0.8699207455608778,1.0,5/30,4.45%,FGF13;DAXX;WNT11;GPRC5A;EPO
prerank,phospholipase inhibitor activity (GO:0004859),0.644497168331567,1.3565390030335607,0.15434083601286175,0.8671667228524711,1.0,4/10,15.13%,ANXA4;ANXA5;ANXA2;SNCB
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5639811708728537,-1.3519020175333203,0.13202933985330073,0.4553553263756401,1.0,7/11,27.56%,CFLAR;CASP9;CASP4;CASP7;CASP2;PYCARD;CASP1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6458539572315438,1.3505910064628366,0.14100486223662884,0.8796128454611707,1.0,1/10,0.66%,B3GALT1
prerank,glucuronosyltransferase activity (GO:0015020),0.5833686708462256,1.3452712296956186,0.14797507788161993,0.8892364673658021,1.0,4/19,9.55%,B4GAT1;LARGE1;CHPF;EXT1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.42825441096799227,-1.3427423324730894,0.11077844311377245,0.467168011111167,1.0,7/25,7.18%,POR;FMO1;NOS3;MICAL3;FMO2;CYP26B1;FMO5
prerank,sterol binding (GO:0032934),0.481173682043818,1.341330145692611,0.1223021582733813,0.8935475005999767,1.0,16/56,11.52%,RORC;SYP;OSBPL9;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;INSIG1;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4
prerank,metallocarboxypeptidase activity (GO:0004181),0.5469157947268886,1.3374935781225676,0.12988826815642457,0.8972614146775384,1.0,6/26,7.94%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,actin binding (GO:0003779),0.43420930015019477,1.3347126172301598,0.06708595387840671,0.8975886400924133,1.0,28/170,7.83%,SORBS1;UTRN;PHACTR1;PAWR;PDLIM5;CALD1;COBL;ABLIM1;PHACTR2;PARVA;DAG1;GSN;MICAL2;SSH3;EPS8L2;CXCR4;CORO7;MLPH;LMOD3;CAPZB;TWF1;AVIL;ADD1;DMTN;FLNB;ANG;MICAL1;MSRB2
prerank,GDP binding (GO:0019003),0.47650245360361376,1.3342415251661803,0.10885167464114832,0.8872795755114027,1.0,24/63,23.44%,RAB17;MRAS;RAP1B;RAP1A;RAB9B;ARL3;NRAS;KRAS;RHEB;RAB3B;RAB7A;RAB35;RAB5C;HRAS;RAP2C;DIRAS2;RAB8B;RAB27A;RAB9A;RAB10;MIEF1;GNAI3;ARL8B;RAB31
prerank,lipase activator activity (GO:0060229),0.6391295052867011,1.3291511509694367,0.19008264462809918,0.8970218723134233,1.0,1/10,1.51%,CCL5
prerank,SUMO transferase activity (GO:0019789),0.5850226406172196,1.3283014396479214,0.16510903426791276,0.8886508315372724,1.0,7/16,15.22%,HDAC4;MUL1;NSMCE2;PIAS1;PIAS3;CBX4;MDM2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.33079733117859256,-1.3238293100542375,0.023076923076923078,0.5001830844204187,1.0,24/80,25.53%,KCNK2;KCNT2;KCND2;KCNN2;PKD2;KCNQ4;KCNJ2;HCN2;KCNJ12;KCNJ6;KCNC1;KCNJ10;KCNMA1;KCNH5;KCNQ3;HCN1;KCNJ8;KCNJ15;KCNIP2;KCND1;KCNC3;KCNB2;KCNK1;KCNJ3
prerank,general transcription initiation factor binding (GO:0140296),-0.42474279960785766,-1.3233546503852074,0.12418300653594772,0.49140475514903725,1.0,12/25,27.99%,AR;ESR1;TAF1B;RUVBL1;TAF12;THAP7;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,deubiquitinase activity (GO:0101005),0.4522206769091176,1.319330425794276,0.10593713620488941,0.9145610193322405,1.0,27/88,18.27%,USP53;MINDY2;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;MINDY4;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5110129800162878,1.3192041763183937,0.12195121951219512,0.9031738208224809,1.0,17/35,20.85%,FOS;SMARCB1;PIH1D1;TAF1C;ZBTB17;UBTF;SMARCA4;DR1;MMP12;MYC;FOXP1;TBPL1;H3-3A;PARK7;TBP;SNAPC3;KLF10
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5694347892613213,1.3191667190064857,0.17262830482115085,0.8917474900592266,1.0,8/17,23.42%,DHCR7;SRD5A3;PECR;BLVRA;TM7SF2;DECR2;MECR;DECR1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6342501256349937,1.3171016253507355,0.175,0.8774874004887453,1.0,2/10,5.45%,DUSP10;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6342501256349937,1.3171016253507355,0.175,0.8774874004887453,1.0,2/10,5.45%,DUSP10;DUSP1
prerank,protein tyrosine kinase activity (GO:0004713),-0.3194893067979391,-1.3168109694580663,0.0423728813559322,0.4974765258271683,1.0,32/108,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;BAZ1B;EPHB2;EPHB4;ROR2;BMX;PKDCC;NTRK2;JAK2;ERBB4;FGFR2;RYK;KIT;ABL2;IGF1R;TYK2;FGFR4;FLT4;RET;EPHA5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5223990371095271,1.310263954223075,0.15208613728129206,0.8950317219456188,1.0,7/32,15.76%,EGLN3;KDM4B;EGLN2;RIOX2;KDM4C;TET1;JMJD4
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6287740139842273,1.3084865507840056,0.19155844155844157,0.891142729754635,1.0,4/10,19.31%,DAXX;PML;FAN1;IDE
prerank,low-density lipoprotein particle binding (GO:0030169),0.5828797483278532,1.3082116897649219,0.17984496124031008,0.8816626991103108,1.0,2/16,1.18%,CDH13;LDLR
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.573319905139357,1.3015678470362781,0.17535545023696683,0.8977975558094433,1.0,5/14,5.53%,COL4A3;NGF;TIMP4;TIMP1;TIMP2
prerank,E-box binding (GO:0070888),-0.389483881571465,-1.2995665459067984,0.10839160839160839,0.5305621393916926,1.0,5/34,9.23%,TCF4;ZEB1;MITF;ATOH8;PPARG
prerank,deoxyribonuclease activity (GO:0004536),0.5896352968870077,1.2990861656072097,0.21207430340557276,0.8974841126726164,1.0,8/14,23.59%,MRE11;DNASE1L2;ERCC5;MBD4;DNASE1L1;ERCC4;MAP1S;APEX1
prerank,hexosyltransferase activity (GO:0016758),0.43382603926927654,1.296804138750209,0.12374581939799331,0.8966119889080179,1.0,19/101,13.78%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;TMTC1;A4GALT;GCNT2;LARGE1;CHPF;MTAP;EXT1;PIGZ;HEXB;ALG1;CHPF2;MGAT4C;ALG12;ALG5
prerank,cadherin binding (GO:0045296),0.409252743702793,1.2958091483054817,0.043522267206477734,0.890096762088992,1.0,62/315,12.97%,CDH1;PHLDB2;CDH13;BAIAP2L1;PLCB3;PDLIM5;CALD1;TJP2;FMNL2;TJP1;AHNAK;STXBP6;PARVA;TMOD3;NIBAN2;PKP4;NDRG1;MPRIP;ARHGAP18;EPS8L2;GPRC5A;SH3GLB2;CTNNA1;EHD1;PPP1R13L;TRIM25;SPTBN2;PFKP;S100A11;CAPZB;PAICS;TWF1;PKM;MRE11;ADD1;TES;HCFC1;ANK3;CC2D1A;ANXA2;FLNB;CLIC1;IQGAP1;CHMP4B;GOLGA3;PI4KA;YWHAB;BAG3;EZR;ABI1;PLEC;SPTAN1;ARFIP2;CDH4;YWHAZ;FASN;ARGLU1;RPS26;EIF4G2;OLA1;ESYT2;EEF1D
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5054532545592905,-1.292459227087451,0.17142857142857143,0.538122309757634,1.0,5/12,20.98%,ENTPD1;CANT1;ENTPD3;ENTPD5;ENTPD6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5166855862947708,-1.2894263038608174,0.1658291457286432,0.5363909411207354,1.0,4/12,5.07%,LTBP1;ENG;ACVRL1;BMPR1B
prerank,protein kinase C activity (GO:0004697),0.5732436332985029,1.2890174632285465,0.1981279251170047,0.9084162436051397,1.0,1/14,0.09%,PRKCB
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4295444392667278,-1.287566943990718,0.1490066225165563,0.5312249519576395,1.0,11/21,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4155726977479146,-1.2865180143699844,0.16225165562913907,0.5246071779402245,1.0,11/23,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.533946757921747,1.285789250404242,0.18382352941176472,0.9107543606511936,1.0,4/23,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,double-stranded RNA binding (GO:0003725),0.45742556379550714,1.2836685449673624,0.16489988221436985,0.9094203649270777,1.0,18/70,15.49%,MBNL1;STRBP;VIM;DGCR8;MTDH;TARBP2;MSN;SIDT2;EIF4B;ILF2;FXR1;DUS2;ZFR2;APTX;EIF4A1;TLR3;DHX9;OAS2
prerank,alanine transmembrane transporter activity (GO:0022858),0.5884547104303265,1.2776810571642687,0.2006172839506173,0.9235396713808434,1.0,3/12,10.87%,SLC36A3;SLC36A4;SLC1A4
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5075515126655348,-1.2771370326597133,0.18858560794044665,0.5372345465929619,1.0,5/11,14.97%,LEF1;MBD2;GATA2;HMGA2;THAP7
prerank,nuclear localization sequence binding (GO:0008139),0.5538220496659476,1.2761077759750055,0.2003012048192771,0.9200766432179994,1.0,9/18,17.56%,KPNA7;NFKBIA;TNPO2;KPNA4;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5156207284780858,1.2750501219624757,0.16642754662840745,0.9144877981111103,1.0,3/26,6.68%,B3GALT1;B4GALNT2;CHPF
prerank,myosin II binding (GO:0045159),0.6235687710791677,1.2742275609392466,0.21416526138279932,0.9078448837839416,1.0,5/10,21.84%,GSN;LLGL2;MYL4;SHROOM4;LLGL1
prerank,alkali metal ion binding (GO:0031420),0.5807160711320809,1.2739158554207048,0.22435897435897437,0.8996374663636163,1.0,2/13,4.08%,ATP1A2;HDAC4
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5495070818701097,-1.2715059092025542,0.2023529411764706,0.5411733821795265,1.0,6/10,27.56%,CFLAR;CASP9;CASP4;CASP7;CASP2;CASP1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4619392889464936,1.271377005642923,0.16321559074299635,0.9005100110505991,1.0,14/52,16.82%,PRKCB;CNOT6;PPARGC1A;NCOA3;MED30;ENY2;CALCOCO1;DCAF6;MED12;MED24;ZMIZ2;ACTN4;SFR1;KDM1A
prerank,leucine zipper domain binding (GO:0043522),0.6182028564826343,1.2702397456248733,0.20938023450586266,0.8954455167536217,1.0,2/10,3.76%,PAWR;DAPK3
prerank,phosphatase binding (GO:0019902),0.4231163255494665,1.2695014257735209,0.1309655937846837,0.8890247850396048,1.0,24/105,13.36%,NFATC2;MAP3K5;ANK1;MAGI2;GTF2F1;IKBKE;PPP6R3;CHCHD3;SH3RF2;AP3B1;TSC2;ROS1;PXN;BAD;LGALS3;IQGAP1;CRY2;MTMR3;JAK1;MVP;EIF2AK3;ELL;ANAPC4;CARHSP1
prerank,phosphatidic acid binding (GO:0070300),-0.441913955284105,-1.26491946242213,0.17791411042944785,0.5484492106367514,1.0,6/19,10.44%,MARK1;RAPGEF2;PLTP;SMPD3;GSDMD;GRAMD1B
prerank,iron ion binding (GO:0005506),0.47119470485518644,1.2642609911571472,0.18639798488664988,0.9003228200597183,1.0,18/48,23.52%,EGLN3;ALOX5;EGLN2;FDX1;KDM3A;HEPH;CDO1;SCD5;ACO2;TET1;HAAO;ISCA2;TYW5;MELTF;PHF2;AOX1;FTO;FTL
prerank,GTPase activator activity (GO:0005096),-0.2653945860071813,-1.260315664745333,0.0,0.5504569671974805,1.0,75/313,12.13%,PLCB1;DOCK4;FARP1;ALDH1A1;PREX2;DENND4A;ERRFI1;TBC1D4;ARHGAP28;ARHGAP24;ADGRB3;ARHGAP32;RAPGEF2;DENND5B;ARHGAP20;FGD5;RASGRP3;ASAP1;TBC1D12;VAV3;CHN2;DENND1A;DOCK10;PLCE1;RGS5;RASGRF2;RP2;ARHGEF28;CHN1;RASGRP2;RGS3;SH3BP5;RIC1;EIF2B3;RABGAP1L;ARHGAP22;SYDE2;TBC1D30;RALGPS1;RABIF;FNIP1;DOCK8;LRRK2;MTSS2;RALGAPA2;SPATA13;ARHGEF15;ELMOD2;RAB3IL1;RGL1;RIC8B;TIAM1;GARNL3;SGSM3;TBC1D14;ARRB1;FGD3;NF1;NPRL3;WDR41;ELMOD1;NCKAP1L;ARAP3;ALS2;DENND2C;TBC1D5;PGAM5;STARD8;ARHGEF2;RCC1;STXBP5L;LAMTOR1;ACAP2;TBC1D7;DENND4C
prerank,MAP kinase phosphatase activity (GO:0033549),0.5837853224273546,1.2579140611986008,0.22778675282714056,0.9163615699163689,1.0,6/12,26.99%,DUSP10;DUSP1;DUSP3;DUSP16;DUSP29;DUSP8
prerank,TBP-class protein binding (GO:0017025),-0.42255123399401084,-1.2575683215821034,0.14826498422712933,0.5484317529969934,1.0,10/21,27.99%,ESR1;TAF1B;RUVBL1;TAF12;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,phospholipase C activity (GO:0004629),0.511770634869807,1.2531297210578216,0.203757225433526,0.9264374301556538,1.0,4/25,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,5'-3' exonuclease activity (GO:0008409),0.5750788383679474,1.2518180374376153,0.22239031770045387,0.9222921700506538,1.0,6/14,19.73%,FEN1;MRE11;XRN2;FAN1;DCLRE1C;DXO
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4323399865014953,1.2510514772384844,0.17099056603773585,0.9164336108217299,1.0,25/83,18.27%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,lipoprotein particle binding (GO:0071813),0.5348313252905023,1.250643010210892,0.21954887218045113,0.9091595083358426,1.0,2/20,1.18%,CDH13;LDLR
prerank,FMN binding (GO:0010181),-0.5144943290404892,-1.250274566176284,0.20153061224489796,0.5571431896295774,1.0,2/11,2.50%,POR;NOS3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6078353307701034,1.2499597997307845,0.21543408360128619,0.903197041643173,1.0,4/11,12.82%,CNGA2;CNGB3;AQP1;CNGB1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4464384160858048,1.2486840828969012,0.17825537294563842,0.8993243734509203,1.0,13/51,16.24%,SLCO2A1;ANKH;SLC35D3;MCU;SLC25A3;SLC16A2;SLC20A1;CLCN4;SLC22A8;SLC25A14;SLC35E2B;SLC35E2A;SLC4A4
prerank,acetylcholine receptor activity (GO:0015464),0.5247831922775332,1.2485991682803883,0.21664275466284075,0.8911701274177292,1.0,1/22,0.76%,CHRM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5285225915639463,1.2480114570210452,0.22861356932153393,0.8850431855879964,1.0,5/20,11.94%,ABHD5;DGAT1;MOGAT3;MOGAT1;LPCAT2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5183982690787259,1.2478218905722758,0.21030042918454936,0.8775249922990018,1.0,9/22,23.32%,MINDY2;IKBKE;OTUD7B;TAB3;IKBKG;TAB2;PRPF8;RNF168;RNF169
prerank,phospholipase activator activity (GO:0016004),0.5966860599236038,1.2442804152559908,0.24074074074074073,0.8830207285528535,1.0,1/10,1.51%,CCL5
prerank,peptidase inhibitor activity (GO:0030414),0.4873938396542802,1.2438695918288758,0.1937669376693767,0.8764795233133438,1.0,6/33,7.21%,SLPI;SPINT2;TIMP1;TIMP2;PSMF1;GPC3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4607370576738153,1.240918724964981,0.1868279569892473,0.8788000218806507,1.0,7/42,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;CD200;S100A11;ANXA2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.48432106406169534,1.238966731411263,0.21550591327201052,0.8785038108585834,1.0,9/34,8.44%,ARAP1;OGT;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;JPH2;IQGAP1
prerank,fibroblast growth factor binding (GO:0017134),0.5255635702258306,1.2382020050095168,0.2065378900445765,0.8734552441646776,1.0,2/21,1.48%,FGFR1;GPC1
prerank,nuclear export signal receptor activity (GO:0005049),-0.5106330831580869,-1.2380765861851393,0.23195876288659795,0.5782382312558089,1.0,5/11,15.61%,XPO1;EIF4ENIF1;RAN;RANBP17;NUP214
prerank,calcium channel regulator activity (GO:0005246),-0.36626842469826626,-1.2373155876655995,0.16666666666666666,0.5714022556901195,1.0,9/37,12.48%,PRKG1;ITPR1;STIM1;NRXN1;SGK1;STIMATE;CACNG8;REM1;SLC30A1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5303074693632366,-1.2364343881970987,0.20454545454545456,0.5653165239778692,1.0,6/10,31.67%,SETD5;NSD1;NSD3;PRDM9;NSD2;SETD3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2840862756056261,-1.2312062709231455,0.045454545454545456,0.5691114825753065,1.0,36/147,12.58%,DOCK4;FARP1;PREX2;DENND4A;RAPGEF2;DENND5B;FGD5;VAV3;DENND1A;DOCK10;PLCE1;RASGRF2;ARHGEF28;RASGRP2;SH3BP5;RIC1;EIF2B3;RALGPS1;RABIF;FNIP1;DOCK8;SPATA13;ARHGEF15;RAB3IL1;RGL1;RIC8B;TIAM1;FGD3;WDR41;ALS2;DENND2C;ARHGEF2;RCC1;LAMTOR1;DENND4C;RASGEF1A
prerank,protein kinase regulator activity (GO:0019887),0.4175960319630478,1.230610902893613,0.17415730337078653,0.8939670458627245,1.0,27/95,19.01%,FGF13;DAXX;PARVA;CDKN1A;WNT11;QARS1;GPRC5A;EPO;ITPRIP;CCND2;ELP4;YWHAB;GPRC5D;CCND1;SMCR8;CCNL2;PRKAR2A;DUS2;WNK1;DNAJC3;PPP1R1B;HEXIM1;CCNG1;PRKAG1;CAB39;SH3BP5L;TAOK3
prerank,N-acyltransferase activity (GO:0016410),-0.37238831517459614,-1.229404656152603,0.15725806451612903,0.5647969447207917,1.0,9/32,12.82%,TGM2;SAT1;NMT2;CERS4;PLAAT3;NAT10;SMARCE1;CERS5;CERS6
prerank,metalloendopeptidase activity (GO:0004222),0.42821599760516005,1.2280697183951577,0.1893424036281179,0.8954316566743594,1.0,12/76,9.03%,THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1
prerank,metallopeptidase activity (GO:0008237),0.41241697585012543,1.2265087957863554,0.16228070175438597,0.8931016520218622,1.0,20/113,13.26%,ADAM12;THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;ADAM15;PSMD7;MMP12;COPS5;MPND;MYSM1;CHMP1A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.4493860665397996,-1.2234650746938431,0.20689655172413793,0.5707272221435437,1.0,8/15,18.52%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1;ALDH7A1;ALDH2;ALDH3B1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5828352938999243,1.2213314796508281,0.23924268502581755,0.9047767571359874,1.0,3/11,10.36%,ALDH3A1;DHRS13;AKR1B10
prerank,ribosome binding (GO:0043022),0.4550851340887623,1.2207433893593218,0.2093628088426528,0.899393987232031,1.0,23/46,24.55%,CPEB2;YTHDF1;ZC3H12A;EIF6;RPSA;MRPS27;NAA15;CPEB3;NAA10;PYM1;CCDC47;EEF2;TMEM147;YTHDF3;ETF1;GEMIN5;IGHMBP2;EFL1;GTPBP6;C1QBP;EIF2S1;EIF2A;MAIP1
prerank,vinculin binding (GO:0017166),0.5841618443462149,1.214224664968079,0.25471698113207547,0.9161115805810096,1.0,4/11,6.76%,UTRN;DAG1;CTNNA1;PXN
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5608517854924837,1.2124240041908294,0.2534992223950233,0.9148534245231604,1.0,5/13,15.73%,FEN1;DNASE1L2;DNASE1L1;ENDOV;FAN1
prerank,GABA receptor binding (GO:0050811),0.566368512601388,1.210752472494403,0.2639593908629442,0.9134937626087938,1.0,2/11,10.21%,PLCL2;AKAP5
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5372277111747644,1.2103824128539822,0.2581120943952802,0.9074398862319414,1.0,4/17,6.77%,PITPNM2;ATP10A;PITPNC1;ATP8B2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.34537004090618356,-1.2076038619401126,0.1836734693877551,0.601888901229275,1.0,9/38,12.00%,PLA2G4A;HIP1;DENND1A;SH3PXD2B;DAB2IP;ZFYVE28;PLEKHA4;LANCL2;PLEKHF1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4180566162952601,1.2051077376976445,0.21151586368977673,0.9194357818583944,1.0,17/79,13.98%,CELF2;PABPC4L;DDX5;CPEB2;ZC3H12A;PABPC1L;CELF1;YBX3;UTP23;RBMS3;CPEB3;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH
prerank,bHLH transcription factor binding (GO:0043425),-0.4313925000832234,-1.2014108466345932,0.2222222222222222,0.6092711315978845,1.0,5/19,13.93%,FHL2;TCF12;LMO2;BHLHE40;SMAD3
prerank,ligand-gated anion channel activity (GO:0099095),0.5191405467124774,1.200971541850334,0.2646616541353383,0.9272664027252727,1.0,1/17,0.12%,CFTR
prerank,amyloid-beta binding (GO:0001540),0.41205532253362687,1.2000807342526436,0.19907407407407407,0.9232497970332662,1.0,12/79,9.67%,CLU;COL25A1;LDLR;EPHA4;CACNA1A;ITM2C;PFDN1;CRYAB;TGFB2;FZD5;TLR6;APBB1
prerank,neuropeptide hormone activity (GO:0005184),0.5024946894650739,1.200064071949436,0.24411764705882352,0.9160505074185672,1.0,2/22,2.38%,GAL;PENK
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5693759946091703,1.1996975255274447,0.27960526315789475,0.9100268856862238,1.0,4/12,14.92%,DHRS4;CRYZL1;NQO2;DCXR
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5004311446695799,1.1994558112774092,0.2514367816091954,0.9038117433685422,1.0,4/22,12.40%,CLU;APBB1;AP2A1;MESD
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.44580155403243,-1.1960857905117248,0.23626373626373626,0.6134990504592877,1.0,8/15,24.38%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR
prerank,exoribonuclease activity (GO:0004532),0.5638611793847899,1.1943844921496858,0.2777777777777778,0.9155569684793848,1.0,3/12,8.90%,CNOT6;ZC3H12A;EXOSC3
prerank,cholesterol binding (GO:0015485),0.4411128194586744,1.1934913847796362,0.23684210526315788,0.911813384185359,1.0,15/47,15.04%,SYP;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4;VDAC1;OSBPL5
prerank,phospholipase A2 activity (GO:0004623),0.49032804291058435,1.1923686648883798,0.27793696275071633,0.909142431770768,1.0,2/26,5.57%,PLB1;PLA2G12A
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5607382888601461,1.1899695620573956,0.26537216828478966,0.9104401723735845,1.0,8/12,23.98%,NAPSA;SPPL2B;HM13;BACE1;SPPL3;SPPL2A;DDI2;PSEN1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5456701490152662,1.1890381687079965,0.27386541471048514,0.9068630624051722,1.0,2/13,8.86%,SREBF2;EHHADH
prerank,nucleoside-triphosphatase activity (GO:0017111),0.37614921129932866,1.186977722891684,0.15030674846625766,0.9075403862608731,1.0,63/248,19.43%,CFTR;RAB17;CLU;DYNC1I1;MRAS;RAP1B;ABCD1;EEF1A1;KIF2A;RAP1A;SHOC1;RHOQ;KIF1C;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;TOR1A;BMS1;RAB35;GNAO1;AGAP3;GNAQ;KLC1;GNA13;VPS4B;RHOA;RABL3;OPA1;CHD3;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;DHX9;ARHGDIB;HSP90AA1;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;MYO1E;HBS1L;KIF20B;RNF112;ABCB6;RAB27A;RAB9A;RHOT2;MYO18A
prerank,protein tyrosine kinase binding (GO:1990782),0.4125483510000425,1.1852337968636641,0.23031026252983294,0.9071121592796653,1.0,9/71,7.75%,PITPNM2;ANGPT1;PTPN14;TJP2;EPHA4;PRR7;PITPNM3;SHC1;FIZ1
prerank,cGMP binding (GO:0030553),0.5620938941578241,1.1844645974517851,0.296998420221169,0.9032461387068751,1.0,4/11,12.82%,PDE5A;CNGA2;CNGB3;CNGB1
prerank,adenyl nucleotide binding (GO:0030554),0.5690017923526934,1.184214845765536,0.2901134521880065,0.8910287376226415,1.0,5/11,15.51%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5690017923526934,1.184214845765536,0.2901134521880065,0.8910287376226415,1.0,5/11,15.51%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,G protein-coupled receptor activity (GO:0004930),0.3717625376577191,1.181923842146383,0.17647058823529413,0.8924832129849183,1.0,21/239,11.56%,ADRA1B;AGTR1;GPR4;LPAR1;OPN1SW;LPAR4;PROKR2;CXCR4;ADGRL2;CCR10;ADGRD1;CRHR2;GPR75;GRM2;LGR4;HCRTR1;ADGRG2;ADGRG6;TPRA1;GPR63;GABBR2
prerank,endopeptidase inhibitor activity (GO:0004866),0.404543955380605,1.1811693109441794,0.24434389140271492,0.8888024384274213,1.0,13/82,10.39%,COL4A3;SLPI;CRB2;SPINT2;NGF;TIMP4;SERPINC1;TIMP1;TIMP2;ANXA2;PSMF1;SERPINB8;CARD16
prerank,nuclear receptor binding (GO:0016922),0.39530094432548757,1.1804763132618035,0.21555555555555556,0.8847188101173523,1.0,30/111,20.23%,PRKCB;DAXX;PPARGC1A;NCOA3;DDX5;EP300;LCOR;MED30;LATS1;TGFB1I1;TCF7L2;GAS2L1;BCAS3;KDM3A;KDM4C;SMARCA4;NCOR1;MED12;MED24;FOXP1;NCOR2;ACTN4;KDM1A;PRPF6;PARK7;ZBTB7A;YWHAH;TACC2;DCAF1;PRMT2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5428281141241101,1.1798607071002751,0.2820919175911252,0.8804561179119612,1.0,6/13,14.35%,CSK;EZR;PKIA;GSK3A;PRKAR2A;GSK3B
prerank,kinase inhibitor activity (GO:0019210),0.455061345269377,1.1792489520582219,0.2618724559023066,0.8762388334440424,1.0,12/33,19.01%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;SH3BP5L;TAOK3
prerank,endonuclease activity (GO:0004519),0.4418155128868152,1.1790925737492952,0.24783147459727387,0.87068219867977,1.0,12/49,13.77%,ZC3H12A;FEN1;KHNYN;RNASEL;MRE11;ANG;TSNAX;YBEY;LACTB2;ERCC5;MBD4;REXO4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4835537845889439,1.1774235664632036,0.260431654676259,0.870025480769378,1.0,6/24,9.99%,IP6K1;PMVK;CMPK1;PPIP5K2;AK3;AK5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.4881225713609725,-1.1715209011917322,0.284688995215311,0.6681222962806506,1.0,3/10,9.87%,PRKAG2;PKIG;PRKAR2B
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4266713503393589,-1.17079769112791,0.2485207100591716,0.6525597769503142,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4266713503393589,-1.17079769112791,0.2485207100591716,0.6525597769503142,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,solute:proton symporter activity (GO:0015295),0.5237991116690923,1.1700602600225045,0.2888198757763975,0.88859569130274,1.0,3/16,5.97%,SLC36A3;SLC25A3;CTNS
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5379679602173678,1.1663132351018173,0.29133858267716534,0.8954177703494659,1.0,5/13,19.15%,SLC66A1;SLC3A1;SLC7A6;SLC7A3;SLC38A7
prerank,protein kinase activator activity (GO:0030295),0.4181791874769506,1.165517074845159,0.24014336917562723,0.8922749268986424,1.0,11/60,10.16%,FGF13;DAXX;CDKN1A;WNT11;GPRC5A;EPO;ERBB3;IQGAP1;GPRC5D;MAP2K2;ABI1
prerank,lipoprotein particle receptor binding (GO:0070325),0.4667949952612755,1.1635060687610834,0.2917251051893408,0.8930811061162222,1.0,6/27,18.14%,CLU;APBB1;AP2A1;MESD;RELN;APBB3
prerank,solute:anion antiporter activity (GO:0140323),-0.4414922445998052,-1.1623269209521456,0.25770308123249297,0.6652204774175999,1.0,2/14,1.56%,SLC7A11;SLC26A7
prerank,omega peptidase activity (GO:0008242),0.39831825932473364,1.1613154082668036,0.2570093457943925,0.8945212885264433,1.0,25/89,18.27%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,carboxy-lyase activity (GO:0016831),0.46893103173286615,1.1610562330071457,0.2838235294117647,0.8895838694609487,1.0,10/23,22.87%,ECHDC1;AZIN1;UMPS;CSAD;PPCDC;PCK2;PISD;GAD1;UXS1;MLYCD
prerank,nuclear import signal receptor activity (GO:0061608),0.5186143415954471,1.1609182336776067,0.294478527607362,0.8842175704606141,1.0,8/15,20.56%,KPNA7;TNPO2;KPNA4;TNPO1;RANBP6;IPO4;KPNA1;HIKESHI
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4210629500767184,-1.1603600145864719,0.2784090909090909,0.6616051450566519,1.0,3/16,5.61%,SLC13A3;SLC1A5;SLC1A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.41834489015722626,1.1594743352019476,0.27812113720642767,0.8830620100118619,1.0,21/57,21.43%,NDUFV1;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,tRNA binding (GO:0000049),0.42651359919488074,1.1479655878983723,0.29274292742927427,0.915701162285296,1.0,22/43,24.38%,EEF1A1;FARS2;ELP5;THG1L;AARS1;MRPS27;PSTK;SARS1;SARS2;TRNT1;TRNAU1AP;CTU1;EIF2AK4;DARS2;TRMT10B;HSD17B10;TYW5;YARS2;IGHMBP2;NSUN6;KARS1;EIF2A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5430534758480127,1.1477209726895365,0.33665008291873966,0.9107418402216496,1.0,2/11,11.84%,SLC25A47;SLC25A45
prerank,semaphorin receptor binding (GO:0030215),0.4790182561615943,1.1470654047464213,0.3053097345132743,0.9070604734748552,1.0,3/23,2.81%,SEMA3D;PLXNB1;SEMA3B
prerank,methyltransferase activity (GO:0008168),0.4246861034338154,1.1470197998082265,0.28269484808454426,0.9014704707476554,1.0,19/46,27.58%,CARNMT1;NTMT1;BUD23;GAMT;NNMT;AMT;EEF1AKMT3;MEPCE;PRMT1;ARMT1;COQ3;N6AMT1;TRMT11;LRTOMT;FTSJ1;MGMT;EHMT1;EEF1AKMT2;NDUFAF7
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.4013587799927699,-1.1441946860309458,0.2713864306784661,0.6951132127861229,1.0,10/18,25.62%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR;WDR81;AGAP2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39645335260517384,1.1416127016895747,0.2863905325443787,0.914386832217663,1.0,17/75,14.92%,GFUS;ADH7;DHRS4;IMPDH2;HMGCR;ME3;LDHB;PHGDH;PGD;LDHAL6B;EHHADH;AKR1B10;HADHA;HSD17B11;MDH2;HADHB;DCXR
prerank,"DNA binding, bending (GO:0008301)",-0.4309987299195944,-1.1407651969745578,0.28421052631578947,0.6949121624001731,1.0,5/14,17.01%,LEF1;SAP30L;HMGA2;HMGB1;HHEX
prerank,manganese ion binding (GO:0030145),0.4184602347814216,1.1392216184440567,0.28957528957528955,0.9163950949762433,1.0,6/48,5.72%,FAM20C;MPPED2;FEN1;GALNT1;LARGE1;MGAT1
prerank,damaged DNA binding (GO:0003684),0.4231343908348115,1.1386602989799275,0.2928660826032541,0.9124554184266899,1.0,15/44,19.87%,FEN1;EP300;CRY2;SDE2;ERCC5;RPA3;APTX;PCNA;DCLRE1C;DDB1;ERCC2;SMC6;NBN;PNKP;ERCC4
prerank,ATPase activator activity (GO:0001671),-0.37868474993656925,-1.1385646550028001,0.2445141065830721,0.6920430294306639,1.0,8/20,24.18%,ATP1B1;DNAJB4;DNAJA1;DNAJC19;DNAJB2;DNAJC1;DNAJB1;AHSA1
prerank,endopeptidase activity (GO:0004175),0.3624880756469989,1.1384639877861664,0.2329896907216495,0.9075097277699045,1.0,29/257,10.91%,DPP4;THSD4;ADAMTS14;PIK3IP1;MMP9;ADAMTS7;ADAMTSL5;ADAM10;HPN;ADAM33;USP46;USP29;PRSS12;USP10;PRSS36;GZMM;CTSZ;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;PREP;KLK1;USP20;USP24;HP;HPR;USP42
prerank,endodeoxyribonuclease activity (GO:0004520),0.4893575465101643,1.136800603372379,0.31759656652360513,0.9071891866637145,1.0,8/20,19.87%,FEN1;MRE11;ERCC5;MBD4;ENDOV;DCLRE1C;RAD50;ERCC4
prerank,lipase activity (GO:0016298),0.4270917101611903,1.1336609608246482,0.3163138231631382,0.9117968316826386,1.0,4/43,4.98%,PLB1;ABHD5;PITPNM3;ABHD15
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4380702213090764,-1.1332102086798868,0.2892561983471074,0.6976982696119868,1.0,5/13,10.15%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4847640650552689,-1.1319205871124034,0.29873417721518986,0.6926969650248396,1.0,7/10,39.63%,DPYSL5;CAD;OPLAH;CRMP1;DPYSL4;DPEP1;DPYS
prerank,poly-pyrimidine tract binding (GO:0008187),0.4700556227172709,1.130021573473019,0.324438202247191,0.9186904892272355,1.0,7/23,18.82%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2;PTBP1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.43555839043986994,1.1270932599305692,0.32653061224489793,0.9226048605846945,1.0,17/34,27.17%,EEF2KMT;DOT1L;SMYD3;EEF1AKMT3;SETDB1;SETD7;SMYD1;MEN1;ATPSCKMT;ANTKMT;KMT5A;KMT2E;N6AMT1;SMYD2;CAMKMT;EHMT1;EEF1AKMT2
prerank,syntaxin-1 binding (GO:0017075),0.47328679321968103,1.1270651015018291,0.3039647577092511,0.9171576060685946,1.0,4/22,8.19%,UNC13C;SYP;DAPK1;STXBP1
prerank,hyaluronic acid binding (GO:0005540),0.5594936612871696,1.1250290920763344,0.3599320882852292,0.9181609255108942,1.0,3/10,8.14%,CD44;IMPG1;STAB2
prerank,PDZ domain binding (GO:0030165),0.4031607027271246,1.1246972667690105,0.3026481715006305,0.9138389101841807,1.0,7/61,9.59%,CXADR;CFTR;CRIM1;ARHGAP29;CXXC4;MAP2K2;LLGL2
prerank,semaphorin receptor activity (GO:0017154),0.5292539491429799,1.123840932950842,0.34223706176961605,0.9113440589945222,1.0,5/11,16.32%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5224885355003909,1.122038894141935,0.35323383084577115,0.9118642016503411,1.0,5/12,16.82%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,calcium channel inhibitor activity (GO:0019855),-0.4553128711554427,-1.119069391663896,0.30392156862745096,0.7182253524299328,1.0,4/11,17.16%,ITPR1;SLC30A1;PACSIN3;FKBP1A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.44880712748075635,-1.117602784626775,0.3290155440414508,0.7142602486573563,1.0,6/12,16.25%,PIK3CB;PIK3R6;PIK3CD;PIK3R3;PIK3C3;IPMK
prerank,lysophospholipase activity (GO:0004622),0.46899229285763017,1.1174442399126174,0.33580980683506684,0.9216879251654484,1.0,1/20,0.17%,PLB1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.366947473785321,-1.1168323216383271,0.2773972602739726,0.7081888566032882,1.0,9/25,17.58%,HIP1;TGFA;ERBB4;PLSCR1;LINGO1;GRB2;CNOT9;ATXN2;EGF
prerank,steroid hydroxylase activity (GO:0008395),-0.4002037145462085,-1.1142224402264125,0.3240223463687151,0.7069890695884149,1.0,2/16,4.52%,CYP7B1;CYP1B1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4667700513101628,1.1122204763316508,0.3469079939668175,0.9332182370158836,1.0,5/20,10.17%,TJP2;CMPK1;AK3;AK6;CASK
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.45175101079406005,-1.112212616453076,0.327319587628866,0.7044419506941964,1.0,3/11,14.11%,ITPR1;MCOLN1;RYR2
prerank,mRNA methyltransferase activity (GO:0008174),-0.4443790013105785,-1.110750464957108,0.3464566929133858,0.7005586511946092,1.0,3/12,10.23%,METTL8;METTL16;TRMT61B
prerank,death receptor activity (GO:0005035),0.5274697148536012,1.1096701090964112,0.3567921440261866,0.9358643917207644,1.0,3/11,9.00%,EDA2R;TNFRSF10B;TNFRSF1A
prerank,RNA stem-loop binding (GO:0035613),0.5211979965157326,1.108680629943654,0.3528481012658228,0.9335874197286277,1.0,4/12,15.31%,ZC3H12A;EPRS1;CPEB3;DHX9
prerank,neuropeptide receptor binding (GO:0071855),0.509097727452459,1.1082694933195096,0.3546875,0.9294399553950248,1.0,1/14,1.37%,GAL
prerank,poly(U) RNA binding (GO:0008266),0.4683599780248212,1.1026854405283162,0.3465491923641703,0.9410531307752816,1.0,6/20,18.29%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2
prerank,antiporter activity (GO:0015297),0.46880935225675235,1.1012721438300017,0.34235668789808915,0.9403702562405608,1.0,8/20,22.74%,SLC35D3;CLCN4;SLC25A14;SLC35E2B;SLC35E2A;ATP1A3;SLC35C2;SLC25A11
prerank,phospholipase activity (GO:0004620),0.38908746172463615,1.0984168842191715,0.325,0.9440956525953821,1.0,6/67,7.22%,PLB1;PLCB3;NAPEPLD;PITPNM3;PLA2G12A;PLCL1
prerank,phospholipid transfer activity (GO:0120014),0.46122447416686674,1.0938862028840959,0.3466666666666667,0.9530939984818969,1.0,3/21,6.32%,PITPNM2;PITPNC1;PRELID3B
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5216128716327648,1.0925874996355562,0.35973597359735976,0.9519058989587327,1.0,2/11,10.20%,PPP1R14B;PPP1R11
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3371549014867803,-1.0916686534018483,0.3176470588235294,0.7417704843970073,1.0,4/29,5.61%,SLC13A3;SLC26A7;SLC1A5;SLC1A1
prerank,retinoid binding (GO:0005501),-0.363859854388284,-1.0911854187775083,0.32515337423312884,0.7347250347265444,1.0,3/22,5.05%,ALDH1A2;NR2F2;CYP26B1
prerank,CoA hydrolase activity (GO:0016289),0.4902117958982166,1.091082913935124,0.3675344563552833,0.9514240068953739,1.0,2/16,2.68%,ACOT8;ABCD1
prerank,histone deacetylase activity (GO:0004407),0.4708063930579356,1.0909501994271855,0.3654434250764526,0.9466429292799284,1.0,5/19,17.34%,HDAC5;HDAC4;HDAC3;MIER2;HDAC6
prerank,protein kinase inhibitor activity (GO:0004860),0.4099187002062719,1.089007159674526,0.3484455958549223,0.9476524895687449,1.0,13/42,19.01%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;CAMK2N1;SH3BP5L;TAOK3
prerank,retinoid X receptor binding (GO:0046965),-0.4391939498860484,-1.0887264804062344,0.33773087071240104,0.7334788012874636,1.0,5/11,21.27%,TACC1;NSD1;PPARG;NR4A2;NRIP1
prerank,small GTPase binding (GO:0031267),0.3514642673815868,1.0887188697665897,0.3291139240506329,0.9434428381021891,1.0,40/170,16.13%,RNF152;STK19;SRGAP2;NDRG1;AKAP13;CAV1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;FLNA;RIN3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.43288749385564906,-1.0861333501253263,0.3477088948787062,0.732084484997376,1.0,6/12,20.09%,TENT5A;PAPOLA;PAPOLG;TENT5D;TENT2;PAPOLB
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5031963857320213,1.085794468393571,0.3934959349593496,0.947855312901214,1.0,1/12,0.78%,CYFIP2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.46163677722203156,1.0844877554284218,0.3798219584569733,0.9469192669153667,1.0,4/22,10.11%,DUSP10;DUSP12;DUSP1;MTMR3
prerank,heme binding (GO:0020037),-0.28438747691285243,-1.0833945673633036,0.3212121212121212,0.7314011134936288,1.0,14/65,10.38%,GUCY1B1;NOS3;PTGIS;FLVCR2;NOX4;CYP1B1;CYP26B1;PTGS2;HEBP1;PGRMC2;JAK2;COX15;RSAD1;SDHC
prerank,RNA polymerase core enzyme binding (GO:0043175),0.43378865437869185,1.0822176627413216,0.3784860557768924,0.9491158440169551,1.0,9/33,16.79%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2;SPTY2D1
prerank,transforming growth factor beta binding (GO:0050431),0.45026305198956296,1.0783795608772693,0.34820143884892085,0.9557355340637653,1.0,3/23,5.03%,CD109;TWSG1;LTBP4
prerank,cation transmembrane transporter activity (GO:0008324),0.3993613135072751,1.0772194660906693,0.3870967741935484,0.9543859150192248,1.0,16/48,20.84%,SLC36A3;SLC66A1;OCA2;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;PKD2L1;SLC41A1;SLC6A7;SLC7A3;SLC8B1;SLC38A7;SLC25A2;SLC38A6
prerank,voltage-gated anion channel activity (GO:0008308),0.4817400804750635,1.0746284746313652,0.3736434108527132,0.9573878180566241,1.0,6/15,15.05%,VDAC2;CLCN4;ANO6;VDAC1;GPR89B;GPR89A
prerank,protein kinase binding (GO:0019901),0.3329554943679057,1.0723274311855608,0.30792377131394183,0.9593030327191177,1.0,115/480,18.46%,PRKCB;UTRN;ANK2;DAXX;PDLIM5;TJP2;TRIB2;EPHA4;GRK5;CDKN1A;ADAM10;EMP2;CAV1;MAVS;NBEAL2;EEF1A1;HDAC5;QARS1;PRR7;FOXO3;RELB;AP2A2;DUSP10;CAVIN2;HSPB1;PPP1R15A;PIH1D1;DUSP1;CAV2;BCL2L1;RNF138;FOXM1;SPRED3;SHC1;PFKFB2;CSK;MAPK7;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;PARD6B;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CDK5RAP1;ACTB;PTPN6;EZR;CCND1;DACT2;SMCR8;NELL2;ZC3HC1;EXOC2;PKIA;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;PPM1D;MAP3K13;VDAC1;GSK3A;IRAK1;SHC2;PRKAR2A;GSK3B;CCDC88A;WNK1;DNAJC3;TNIP1;TNNI3;HSP90AA1;RB1CC1;ITGB2;PRKCSH;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;ABL1;PRKAG1;NSF;CDC25B;MAPKAPK2;MTCP1;CDH5;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;RARA;ATF2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3471437458120156,-1.0718794801897107,0.33650793650793653,0.7537052717391737,1.0,5/23,8.09%,HIP1;SH3PXD2B;CLVS2;SNX14;PLEKHA4
prerank,lysine N-methyltransferase activity (GO:0016278),0.4456058292957146,1.0711821430097186,0.3661360347322721,0.9578581182934263,1.0,9/20,27.17%,EEF2KMT;EEF1AKMT3;SETD7;ATPSCKMT;ANTKMT;KMT5A;SMYD2;EHMT1;EEF1AKMT2
prerank,phosphatase activator activity (GO:0019211),0.48911978645700144,1.0710861265147846,0.40348101265822783,0.9532279223560544,1.0,2/14,4.99%,GTF2F1;PPP1R15A
prerank,histone acetyltransferase activity (GO:0004402),0.42995722990647356,1.0708804281444535,0.35724331926863573,0.9489661392578629,1.0,4/30,6.61%,NCOA3;EP300;NAA40;KAT6B
prerank,cytokine receptor activity (GO:0004896),0.37334772540519234,1.0685638569409284,0.36469221835075494,0.9509764603085288,1.0,10/83,5.94%,CD44;CRLF1;CCR4;IL17RE;IL17RA;ACKR2;ACKR4;IL3RA;GFRA3;CCRL2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.35812694720993904,-1.0678095141280637,0.35275080906148865,0.7574275736089655,1.0,14/21,52.94%,GRM5;GRM1;CHRNB1;ANXA9;CHRNA4;CHRNB2;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1
prerank,chemoattractant activity (GO:0042056),0.4326850539105589,1.0669724515329335,0.4015957446808511,0.9509948287242201,1.0,5/26,8.78%,CCL5;GDNF;BMP4;LGALS3;VEGFB
prerank,titin binding (GO:0031432),0.4877041268982896,1.0646574376272129,0.41883116883116883,0.953150187134436,1.0,1/13,1.06%,ACTN2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4173543382803523,-1.0623574138236194,0.4,0.7643217695940436,1.0,7/13,21.98%,TARBP1;METTL1;TRMT10A;THUMPD2;TRMT5;TRMT1L;TRMT10C
prerank,guanyl ribonucleotide binding (GO:0032561),0.34156045138113683,1.0608561062692445,0.38284518828451886,0.959661546410776,1.0,47/196,19.24%,RAB17;PDE5A;MPPED2;MRAS;RAP1B;EEF1A1;RAP1A;RAB9B;ARL4A;CNGA2;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CNGB3;RAB3B;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;CNGB1;ARF4;RHOU;RAB5C;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2;RAB8B;SLC19A1;RNF112;RAB27A;RAB9A;RHOT2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4204993713670269,-1.0574523742607884,0.3882978723404255,0.7694260308705833,1.0,6/12,19.38%,PIK3R1;SH2B3;GAB2;BLNK;SH2B2;TRADD
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5110673556691889,1.0567494952623495,0.4242928452579035,0.9669521269356323,1.0,4/11,13.91%,NAA40;NAA15;NAA20;NAA10
prerank,ligand-gated calcium channel activity (GO:0099604),-0.36677234381033696,-1.0563617511304393,0.39692307692307693,0.7643031393855422,1.0,4/19,7.83%,ITPR1;GRIN2A;GRIN2B;MCOLN1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4979615127641658,1.0540668367205304,0.4175084175084175,0.9701918819754292,1.0,5/11,17.30%,RBX1;UBE4A;UBR5;PRPF19;STUB1
prerank,LRR domain binding (GO:0030275),0.4817599895313453,1.0520488590380073,0.416,0.971609590039143,1.0,4/14,14.30%,PAWR;DAPK3;LRRFIP2;ZXDC
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.49116790443528663,1.0507342887161757,0.4040066777963272,0.9707428502902689,1.0,4/12,19.84%,FOS;TBPL1;H3-3A;TBP
prerank,syntaxin binding (GO:0019905),0.3746405957709188,1.0493929398556294,0.3926453143534994,0.9699576473360445,1.0,19/61,17.46%,UNC13C;SYP;CACNA1A;BLOC1S6;DAPK1;STXBP1;VPS54;VPS11;PTPN2;NAPA;NAPB;VPS52;VPS18;SYT6;STX16;SYT12;ABL1;NSF;VAMP1
prerank,monocarboxylic acid binding (GO:0033293),0.45250273088983367,1.0475820611013449,0.416793893129771,0.9707161401620659,1.0,1/18,0.90%,NAPEPLD
prerank,protein serine/threonine kinase activity (GO:0004674),0.3259165665148421,1.0474428669693434,0.3873239436619718,0.9663703990358494,1.0,74/335,17.86%,PRKCB;STK19;MAP3K8;PRKAA2;LIMK2;FAM20C;NRBP2;MAP3K5;GRK5;TSSK6;TSSK4;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;CAMKK1;STK39;SIK3;MAPK15;MAPK7;MAP3K4;CDK16;PLK3;ILK;LATS1;DYRK1B;STK16;OXSR1;MAPK9;AURKC;BCR;LMTK2;TRIO;RAF1;CASK;SRPK2;CDKL4;GRK2;PKMYT1;CSNK1E;MARK4;TGFBR2;EIF2AK3;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;TESK1;AAK1;PAK6;TTK;ATR;PRKCZ;MAP3K6;MAPK6;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PRKCQ
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4324291145695065,1.04730819870586,0.3994252873563218,0.9621866137547399,1.0,5/24,6.25%,MKNK2;PTK2B;DAPK1;CAMKK1;PHKA2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3550172019673345,-1.0466771393873826,0.3746130030959752,0.7826624530115389,1.0,5/20,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,lysine-acetylated histone binding (GO:0070577),0.44549334730314716,1.046258198143506,0.4017725258493353,0.955954338872995,1.0,7/20,17.89%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),0.44549334730314716,1.046258198143506,0.4017725258493353,0.955954338872995,1.0,7/20,17.89%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,H4 histone acetyltransferase activity (GO:0010485),0.504055120433131,1.0455067276625527,0.4368932038834951,0.9536915762687221,1.0,5/10,21.64%,EP300;NAA40;ATF2;USP22;HAT1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4048040999584993,1.045246175660172,0.4049159120310479,0.9499814438620966,1.0,5/38,8.76%,SLPI;SPINT2;SERPINC1;ANXA2;SERPINB8
prerank,glutamate receptor binding (GO:0035254),-0.3651829580366116,-1.045077625940506,0.3970149253731343,0.7793416834827067,1.0,4/17,4.94%,HIP1;GNAS;SHANK3;SHISA6
prerank,sequence-specific mRNA binding (GO:1990825),-0.43813816367860625,-1.0449406269208976,0.415041782729805,0.7721296077849212,1.0,6/10,27.60%,DHFR;SHFL;LARP6;TYMS;FMR1;RBM24
prerank,RNA polymerase II complex binding (GO:0000993),0.416518155913855,1.0427015169187055,0.4057971014492754,0.9531659475971175,1.0,8/32,15.54%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,active ion transmembrane transporter activity (GO:0022853),0.4047948299472076,1.0413819662862591,0.42133333333333334,0.9526503398908978,1.0,8/37,11.30%,SLCO2A1;ATP13A3;COX5A;COX8A;UQCRC1;COX7A2L;COX5B;SLC22A8
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.39081101325998496,-1.0406735166949206,0.40947075208913647,0.7760220718556725,1.0,12/15,50.60%,P2RY14;P2RY1;P2RY12;PTAFR;GPR34;P2RX5;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3248360116946247,1.0391170345922498,0.40835030549898166,0.9548085588302875,1.0,63/269,17.99%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;PRR7;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;DDRGK1;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;SLC22A18;PML;SUMO2;SUMO3;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;STAM;TRIM37;TSG101
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4759685843099116,1.0387074665242022,0.41867954911433175,0.9515965522244031,1.0,4/13,15.33%,SH3BP4;CCDC88A;ITGB1BP1;ARHGDIB
prerank,snRNA binding (GO:0017069),0.38585004573138204,1.0350255411802358,0.4126778783958603,0.9576210312583441,1.0,13/42,24.63%,LSM10;SNRNP70;LARP7;LSM4;DDX39B;SF3B3;MEPCE;HEXIM1;TUT1;PRPF8;GEMIN5;CDK9;SNRPB2
prerank,microtubule binding (GO:0008017),0.3314874844928248,1.0346208858822532,0.42901554404145076,0.9543570039804455,1.0,48/222,19.20%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;NDRG1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;KIF1C;EML2;KIF1B;MAP4;CLIP4;KRIT1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;PAFAH1B1;MARK4;ABRAXAS1;OPA1;TPGS1;CCDC88A;GAPDH;DNM1L;MAP1LC3B;REEP4;KIF17;CAMSAP1;RMDN3;HDAC6;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TUBGCP5;HOOK3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.4000585808217871,1.033927644771785,0.412483039348711,0.9476235493410281,1.0,13/34,23.39%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.4000585808217871,1.033927644771785,0.412483039348711,0.9476235493410281,1.0,13/34,23.39%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,phosphate ion binding (GO:0042301),-0.43838157708034947,-1.0320151468864047,0.4019607843137255,0.7915197803469685,1.0,4/10,21.50%,RPH3A;PDE2A;PNP;ADSS1
prerank,calcium-release channel activity (GO:0015278),0.45402095656928976,1.0318189378247702,0.4397496087636933,0.9493845440455203,1.0,5/17,13.38%,ITPR2;TPCN1;ITPR3;RASA3;TRPM2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.36403928228588456,1.0318083913542524,0.41477949940405245,0.9451201494831049,1.0,16/72,10.88%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,glycerophospholipid flippase activity (GO:0140333),0.5007179374094866,1.031288253062416,0.44518272425249167,0.942290211419022,1.0,2/11,6.77%,ATP10A;ATP8B2
prerank,FAD binding (GO:0071949),0.42070481839108664,1.030710951013217,0.43447293447293445,0.9397529190166946,1.0,5/24,8.61%,MICAL2;CYB5R3;NQO2;MICAL1;CRY2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3523293318951956,-1.0291344521502845,0.38513513513513514,0.7917457026540707,1.0,8/21,38.36%,GRIK2;GLRB;CHRNB1;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6
prerank,ion channel inhibitor activity (GO:0008200),0.39181686202516963,1.0285014044024077,0.4260515603799186,0.9418679321363205,1.0,7/35,15.15%,CFTR;MCUB;VTI1B;RASA1;WNK1;NEDD4;TNNI3
prerank,potassium channel regulator activity (GO:0015459),-0.2814341177746571,-1.0271650923064155,0.4020100502512563,0.7895123929143523,1.0,10/49,16.57%,DPP10;SGK1;ABCC9;KCNIP4;WNK2;KCNIP3;KCNIP1;DPP6;KCNMB4;SLC5A3
prerank,GTPase binding (GO:0051020),0.3277585304972031,1.0271324695753177,0.43049792531120334,0.9415933853496953,1.0,42/195,15.66%,RNF152;STK19;SRGAP2;NDRG1;AKAP13;CAV1;EPRS1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;RASA1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;HSP90AA1;FLNA
prerank,Notch binding (GO:0005112),-0.34541399203580986,-1.026632690153996,0.4084967320261438,0.7835492873913491,1.0,6/22,13.64%,JAG1;MEGF10;DTX1;JAG2;NOTCH4;CCN3
prerank,acylglycerol lipase activity (GO:0047372),-0.414439360774738,-1.0262326816579896,0.45714285714285713,0.7773107121483471,1.0,5/11,17.24%,ABHD3;MGLL;LIPE;ABHD12;ABHD2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.43590547675780944,1.0258049181229087,0.42946708463949845,0.9370081932808209,1.0,11/16,31.10%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.43590547675780944,1.0258049181229087,0.42946708463949845,0.9370081932808209,1.0,11/16,31.10%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31732652010899703,1.025711911770984,0.406,0.9332426901238158,1.0,117/731,14.33%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;FOXN3;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4121172996205154,-1.0249594532946549,0.4166666666666667,0.7734061434127789,1.0,6/11,10.97%,ITPR1;TRPC3;TRPC4;RPH3A;TRPC6;TRPC5
prerank,ribonuclease activity (GO:0004540),0.38180396451401993,1.0248049568056812,0.4331288343558282,0.9317656815613768,1.0,10/56,10.60%,CNOT6;ZC3H12A;KHNYN;RNASEL;ANG;TSNAX;EXOSC3;YBEY;RNASE3;LACTB2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3795778939223764,-1.0246040546934108,0.43765903307888043,0.7673177611693808,1.0,1/15,0.46%,PLA2G4A
prerank,gated channel activity (GO:0022836),0.46582177262033264,1.0243934137850026,0.4503105590062112,0.928841745828624,1.0,6/14,21.03%,TMC6;TMC2;PACC1;TMEM63B;TMC4;TMEM266
prerank,exonuclease activity (GO:0004527),0.3798527740000721,1.02174707621793,0.4292866082603254,0.9319461377208884,1.0,13/46,20.43%,CNOT6;ZC3H12A;FEN1;MRE11;XRN2;EXOSC3;POLG;REXO4;FAN1;DCLRE1C;RAD50;DXO;APEX2
prerank,actin monomer binding (GO:0003785),0.4292281831275767,1.0209745117595257,0.44523470839260315,0.9299843045908249,1.0,6/22,16.81%,COBL;LMOD3;TWF1;MYL4;PFN2;ABL1
prerank,nuclease activity (GO:0004518),0.37552564830947716,1.0206079769195522,0.4606741573033708,0.9268882362129734,1.0,17/52,23.59%,ZC3H12A;FEN1;RNASEL;MRE11;ANG;XRN2;RNASE3;DNASE1L2;ERCC5;DNASE1L1;REXO4;RNASE4;RNASE7;PNKP;N4BP2;MAP1S;APEX1
prerank,ribosomal large subunit binding (GO:0043023),0.49034854633408254,1.0204723822790727,0.4360655737704918,0.9233304524479686,1.0,3/11,9.96%,CPEB2;EIF6;LTN1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.42366552062964996,-1.0203002631151183,0.44155844155844154,0.7711104035763479,1.0,3/10,21.29%,NOX4;NCF2;CYBB
prerank,diacylglycerol kinase activity (GO:0004143),-0.40760228774018287,-1.01964629174453,0.4433249370277078,0.7656685714860826,1.0,7/11,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,carbohydrate kinase activity (GO:0019200),0.48727428274489404,1.0190571479056927,0.45499181669394434,0.9230788400691577,1.0,4/11,17.13%,NAGK;HK1;GALK2;GNE
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3321862730902272,-1.0180558031281262,0.4358974358974359,0.7633096175695595,1.0,5/25,9.01%,ZC3HAV1;ART3;PARP14;PARP8;TNKS
prerank,beta-tubulin binding (GO:0048487),0.4026659241060204,1.016802587841037,0.44367176634214184,0.9253758334730897,1.0,2/31,3.65%,FGF13;GJB6
prerank,microtubule motor activity (GO:0003777),0.37505534627185233,1.0165154089864221,0.4161490683229814,0.9222215345311038,1.0,6/51,6.66%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,leak channel activity (GO:0022840),-0.36730453636363636,-1.0161142113841126,0.44193548387096776,0.762026393082783,1.0,3/18,8.33%,KCNK2;KCNK5;PANX1
prerank,actinin binding (GO:0042805),0.4226269504273806,1.01574991144814,0.4407514450867052,0.9204084505332825,1.0,6/21,12.55%,PDLIM5;DAG1;CSRP3;MYOT;PKD2L1;KCNA5
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4108613212156209,1.0155963590593273,0.4415954415954416,0.9169563656787885,1.0,7/26,15.09%,PPP1R14B;LGALS3;LMTK2;PPP1R11;PTN;SET;PPP1R1B
prerank,hydro-lyase activity (GO:0016836),0.38274941554865227,1.0137643687292035,0.44144144144144143,0.9180775563143815,1.0,12/41,18.90%,ECHDC1;UROS;EHHADH;HACD4;ENO2;HADHA;ACO2;AUH;HADHB;ECHS1;PARK7;APIP
prerank,histone methyltransferase activity (GO:0042054),0.3994243877344806,1.013499210993345,0.45392022008253097,0.9149935290222067,1.0,15/32,26.57%,NTMT1;DOT1L;SMYD3;SETDB1;PRMT1;PRMT2;SETD7;SMYD1;MEN1;KMT5A;KMT2C;KMT2E;N6AMT1;SMYD2;EHMT1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3876819134715933,1.0131370917515303,0.45139813581890814,0.9121320147041598,1.0,3/35,1.74%,PLCB3;NAPEPLD;MPPED2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.36957387650308066,1.0118127578412273,0.46124523506988563,0.9117835214109496,1.0,16/49,23.32%,MINDY2;IKBKE;OTUD7B;PSMD4;TAB3;AGAP3;ABRAXAS1;ZFAND6;TNIP1;IKBKG;HDAC6;TAB2;PRPF8;RNF168;UBQLN2;RNF169
prerank,metalloexopeptidase activity (GO:0008235),0.36724820696667765,1.0116739674112971,0.4485749690210657,0.9083764583875376,1.0,6/51,7.94%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31248020135460347,1.0101251557191042,0.467,0.9085529423650479,1.0,117/730,14.33%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,RNA binding (GO:0003723),0.3126535224199311,1.0082759036431825,0.474,0.9097334404636337,1.0,320/1321,20.00%,MBNL1;MSI2;NUDT4;CELF2;NSA2;PPARGC1A;STRBP;AHNAK;VIM;LSM10;PABPC4L;SAMD4A;DDX5;CPEB2;GTF2F1;YTHDF1;ZC3H12A;SRSF2;SLPI;GRWD1;PABPC1L;EEF1A1;SAMD4B;CELF1;DGCR8;PEF1;EPRS1;DIAPH1;RBFOX2;CDC42EP4;CMSS1;CTNNA1;PCDH20;MRPL37;MRPL2;ACIN1;NOP2;YBX3;RBM19;PES1;HSPB1;TRIM25;PPAN;ADK;BUD23;MTDH;UTP11;FARS2;DMGDH;FDPS;KHNYN;SNRNP70;SON;CCDC9;SNRPB;RPS4X;UNK;EIF3L;TARBP2;USP10;SLTM;MRPS7;POLR2A;KIF1C;SRRM2;PKM;RNASEL;ADD1;SUCLG1;MOV10;TES;EIF4A3;SLIRP;ANXA2;UTP23;RBMS3;MAP4;PSMD4;MSN;SSRP1;FLNB;RBM20;DHX32;SMG7;SIDT2;NKAP;UNC50;KRR1;PRRC2C;ANG;RALY;MAK16;TSNAX;LARP7;LSM4;POP4;ABCF1;STXBP1;LGALS3;L1TD1;MAZ;JUN;ELP5;UBTF;DDX39B;RBM8A;XRN2;RPL31;RPSA;EXOSC3;EIF4B;HNRNPH2;SUMO2;POP1;GSPT2;WDR33;RPL22;MOV10L1;ERI3;GTPBP10;MYO5A;AGFG1;EZR;THG1L;PHF5A;AARS1;DBR1;MRPS23;ILF2;RRP12;LUC7L3;BMS1;DDX55;SRPK2;NIP7;MTREX;DHX57;MRPS27;WDR43;KHDC4;LACTB2;SRRM4;R3HDM2;HABP4;PLEC;WDR36;RPL28;CSNK1E;ZMAT3;TBRG4;PWP2;SRSF7;ANKRD17;MDH2;DDX47;SRBD1;YWHAZ;SF3A2;ZCCHC24;FASN;RPS26;POLDIP3;EIF4G2;RBM42;PSTK;MRPL9;NAA15;WDR6;RPP21;ZCCHC8;CPEB3;FRG1;FAM133B;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;GAR1;GOLGB1;CHD3;TUT7;IBA57;CCDC9B;FXR1;RBM10;NOC4L;DAZAP1;LGALS1;RNPS1;HARS2;PNN;RPL10A;REXO4;R3HDM1;NOL6;PINX1;RRP9;CSTF1;TPD52L2;LTA4H;FNDC3A;SRSF9;MRPS15;DCP1A;SRRT;TNPO1;SARS1;SARS2;DUS2;UPF3B;EIF4G1;ALDOA;TRNT1;ENDOV;YARS1;PYM1;RPF1;ZFR2;HADHB;RBM18;UTP14A;APTX;GRSF1;EIF4A1;RBM46;DDX18;TLR3;UTP4;ISY1;FBRSL1;DHX9;EIF5B;HSP90AA1;EIF3B;TRNAU1AP;MBNL2;PABPN1;RBM47;OAS2;IMMT;IMP4;LUC7L2;CCDC47;ACTN4;FLNA;CWC15;FSCN1;UBE2N;MEPCE;MRPS28;MRPS35;CDC5L;RPL14;DUSP11;MEX3D;RRBP1;MAGOHB;MAGOH;EEF2;RBPMS2;ATXN2L;ARHGEF1;CANX;EIF1;CTU1;RPS27A;UBC;PRR3;HEXIM1;SELENOH;RBM28;KDM1A;PRPF40B;DYNC1H1;EIF2AK4;ZYX;PRMT1;ASS1;PRPF6;FARSA;EIF4A2;CLUH;PATL1;PDCD11;SEC23IP;HNRNPA3;PPP1R10;IGF2BP3;IMP3;RBMS2;SRSF1;PARK7;RAE1;SNUPN;UBAP2L;YTHDF3;ROCK2;DARS2;PTBP1;SRSF5;IGF2BP2;UBFD1;TRMT10B;RPL6;MYO18A;ALDH18A1;HDGF;PCBP2;NUCKS1;GCN1;DXO;CSTF3;TRUB2;CDK11B;ANKHD1;WBP4;SF3A3;RPS28;DDX20;HSD17B10
prerank,ubiquitin protein ligase binding (GO:0031625),0.3164201604998933,1.007498070500234,0.4625641025641026,0.9079726337464991,1.0,59/254,17.99%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;SLC22A18;PML;SUMO2;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;TRIM37;TSG101
prerank,adenylate cyclase binding (GO:0008179),-0.41543114308342155,-1.0055935219570886,0.46335078534031415,0.7819354268437166,1.0,3/10,17.45%,ADCY5;CAP2;ADCY2
prerank,CCR chemokine receptor binding (GO:0048020),0.40381830213569486,1.004698308291349,0.4483240223463687,0.9118936447325423,1.0,2/28,5.94%,CCL5;CCRL2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.37610718470920756,1.0029817601774103,0.46838709677419355,0.9124122051655139,1.0,3/38,6.52%,SORBS1;MAGI2;SHC1
prerank,sodium channel regulator activity (GO:0017080),0.38718693164514434,1.0023904695905972,0.4505347593582888,0.9102326923037858,1.0,2/37,3.69%,FGF13;SGK3
prerank,receptor tyrosine kinase binding (GO:0030971),0.3632977627859304,1.0019459011086669,0.4638036809815951,0.9079201606836623,1.0,6/56,7.75%,PITPNM2;ANGPT1;PTPN14;PITPNM3;SHC1;FIZ1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4896510509154303,1.001293606572454,0.4926590538336052,0.9060516975351186,1.0,4/10,27.14%,FEN1;DCLRE1C;APEX1;POLD1
prerank,voltage-gated ion channel activity (GO:0005244),-0.3927955386380591,-1.0011918296281452,0.4361111111111111,0.7862798292025944,1.0,4/14,6.83%,KCND2;CACNA1E;PKD2;VDAC3
prerank,BMP binding (GO:0036122),-0.40927182289161645,-0.9945173180258808,0.4631043256997455,0.7966924734118611,1.0,2/11,1.85%,ENG;GREM2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4359709904466035,0.9938156160706941,0.4779969650986343,0.9208255707742613,1.0,2/17,2.68%,ACOT8;ABCD1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.30017929668118215,-0.9908494478000727,0.45414847161572053,0.7984691951952255,1.0,10/34,17.84%,STK3;IGF2;STRADA;ETAA1;IRGM;ALS2;FAM20A;DBF4;INCENP;MAP2K1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4227792356675217,0.9903671429798826,0.4789391575663027,0.9259955907968637,1.0,1/18,3.45%,HSD17B14
prerank,Hsp90 protein binding (GO:0051879),-0.30385253858469363,-0.9886196149686683,0.4774436090225564,0.7973288238901256,1.0,7/33,9.24%,PACRG;HIF1A;KDR;TSC1;SLC12A2;NPAS2;HSF1
prerank,SH3 domain binding (GO:0017124),0.3542596079699976,0.9871748172973328,0.4725943970767357,0.9306965641455138,1.0,10/62,10.43%,ADAM12;ENAH;ESPN;MAPK15;AFAP1;AFAP1L1;MICAL1;ABI1;AKAP5;ADAM15
prerank,amino acid binding (GO:0016597),-0.2975959248807907,-0.9861012115243303,0.49242424242424243,0.7968088943013334,1.0,19/31,36.31%,NOS3;GRM7;GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;THNSL2;CASTOR1;CAD;GRIN3A;AARS2;SHMT2;GRIN1;GLDC;GCLC;GNMT;NOS2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3972034651990248,0.9857861883038187,0.4699599465954606,0.9306269485187322,1.0,8/33,15.54%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,protein homodimerization activity (GO:0042803),0.30480375403712345,0.9856058304952884,0.533,0.9275121623340983,1.0,115/590,18.79%,CUBN;DPP4;FGFR1;NECTIN3;SRGAP2;CCL5;MAP3K5;PDGFC;ADAM10;FOXP2;S100A6;GDF15;ABCD1;STARD3;DGCR8;TIMM10;EPRS1;S100A10;DAPK3;GDNF;BLOC1S6;CARNMT1;NR6A1;ZBTB16;HSPB1;HARS1;CRYAB;S100A11;TARBP2;RAB11FIP3;IRF3;TSC2;CAV2;BCL2L1;HSPB8;ADD1;NRF1;ZBTB7B;NADK2;GLB1;PSMF1;NQO2;TRIM21;TGFB2;ANG;GALE;HPGDS;CHMP4A;CHMP4B;PML;TMEM192;FOXP3;KMT2A;SHMT1;EXT1;HOOK1;NFS1;ATP5IF1;CR2;PSMD7;PDK2;S100A1;PON3;VPS4B;RABL3;SP1;PHETA2;ERCC5;FXR1;MAP3K13;PAXX;CHMP1A;SLC39A13;FLRT3;IRAK1;SYT6;PHETA1;BNIP3L;CHUK;SARS1;CCDC88A;NAGA;SDCBP2;DNM1L;DNTTIP1;ABCB9;HSP90AA1;IKBKG;SPPL2B;ACTN4;FLNA;GSTM2;TPI1;RBPMS2;TPD52;TBC1D22A;HM13;SLC8B1;FICD;RAP1GAP;STUB1;CHEK2;PDCD6IP;SPPL3;BMPR1A;TRIM37;PDXK;TSG101;HMGCS1;SPPL2A;PARK7;KIF20B;PDLIM4;TOX3;DARS2
prerank,endoribonuclease activity (GO:0004521),0.39467411676462744,0.9848755017125562,0.4695767195767196,0.9257151675000519,1.0,7/32,14.48%,ZC3H12A;KHNYN;RNASEL;TSNAX;YBEY;LACTB2;ENDOV
prerank,adrenergic receptor binding (GO:0031690),-0.3608022595830266,-0.9845026527473754,0.47674418604651164,0.7943065416638196,1.0,3/16,1.74%,RAPGEF2;GNAS;PDE4D
prerank,tubulin binding (GO:0015631),0.31137271280669804,0.9832926624842238,0.5203665987780041,0.9261181533643806,1.0,61/296,18.91%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;DAG1;NDRG1;DIXDC1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;AGTPBP1;KIF1C;EML2;KIF1B;MAP4;KRIT1;AGBL1;GPAA1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;BCAS3;PAFAH1B1;RAB11FIP5;EFHC2;MARK4;ABRAXAS1;BLOC1S2;OPA1;TPGS1;ALDOA;CCDC88A;GAPDH;DNM1L;WASHC1;MAP1LC3B;ARL8A;REEP4;KIF17;CAMSAP1;RMDN3;GIT1;HDAC6;RITA1;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TBCE;TUBGCP5
prerank,calcium ion binding (GO:0005509),0.3085968755306119,0.9809068671497154,0.5217831813576495,0.9284817864343583,1.0,41/323,12.08%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;ANXA8;ANXA8L1;GSN;S100A6;S100A10;OTOF;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;ANXA2;MICU1;DSC3;DSC2;HPGDS;CETN3;IQGAP1;CALR3;CHP1;PCLO;PCDHA4;ITPR3;DNASE1L2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4;MMP12
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.39046319409053976,-0.979215833107666,0.5,0.8010438002949878,1.0,4/13,9.69%,PIP5K1B;PIP4K2A;PIK3CB;PIK3CD
prerank,mRNA binding (GO:0003729),0.3105715187926404,0.9781068037444411,0.5436793422404933,0.9319919071546068,1.0,62/249,20.22%,CELF2;PABPC4L;SAMD4A;DDX5;CPEB2;YTHDF1;ZC3H12A;SLPI;PABPC1L;SAMD4B;CELF1;RBFOX2;YBX3;KHNYN;SNRNP70;UNK;MRPS7;SRRM2;PKM;EIF4A3;UTP23;RBMS3;RBM20;RBM8A;SHMT1;LUC7L3;SRRM4;SRBD1;RPS26;EIF4G2;CPEB3;SYNCRIP;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH;DCP1A;UPF3B;EIF4G1;GRSF1;EIF4A1;RBM46;DHX9;RBM47;LUC7L2;RBPMS2;CLUH;IGF2BP3;RBMS2;SRSF1;PARK7;YTHDF3;PTBP1;SRSF5;IGF2BP2;PCBP2;DXO;CSTF3;ETF1;RPL41
prerank,poly(A) binding (GO:0008143),0.4152837072280097,0.9759912964274874,0.4857142857142857,0.9337539577214411,1.0,4/21,6.95%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,transferrin receptor binding (GO:1990459),0.4841889235920291,0.9758808857087943,0.5208333333333334,0.9304339557588145,1.0,7/10,28.07%,CD81;CHUK;IKBKG;IKBKB;SNX2;HFE;SNX4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.30227282390428606,0.9739805287836775,0.567703109327984,0.9316091133094533,1.0,82/597,14.33%,BNC2;NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;SMAD6;GLI3;HOXA4;HIVEP1;GABPB1;GABPB2;KLF12;GRWD1;HDAC5;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;BEND3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;ZBTB7B;MEF2D;SIX1;JUN;POU3F1;TCF7L2;CRY2;FOXP3;BRD7;NR2C1;ZIC1;NFIB;NFYC;ARID4A;NFIC;SP2;ZW10;CREB3L4;CREB3;NCOR1;CALCOCO1;MEF2B;HOXB5;MAFG;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;MBD4;MLH3;ZNF177;ZFP1;MEF2C;PAX3;FOXP1;IRF2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4099085015428263,-0.9734903793189883,0.5035971223021583,0.8092830514404109,1.0,6/10,23.81%,STAMBPL1;TNFAIP3;OTUD5;ATXN3;CYLD;YOD1
prerank,double-stranded DNA binding (GO:0003690),0.30271565217994445,0.9727019960421157,0.5778894472361809,0.931339751383749,1.0,113/531,21.81%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;GLI3;HOXA4;HIVEP1;KLF12;FEN1;FOXO3;FOS;FOXC2;GLIS2;KLF16;CGGBP1;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;MRE11;ZBTB7B;MEF2D;CENPS;SIX1;JUN;POU3F1;FOXP3;NR2C1;ZIC1;HDGFL3;NFIB;NFIC;SP2;CREB3L4;CREB3;MEF2B;HOXB5;MAFG;SP1;FOXK1;TFEB;ERCC5;GATA3;ZNF177;REXO4;ZFP1;MEF2C;PAX3;FOXP1;IRF2;APTX;DHX9;MBNL2;KLF6;HMBOX1;E2F1;POU4F1;ABL1;CAMTA2;SMAD5;HSF2;DMRTA1;MEOX2;RAD50;RARA;PARK7;ATF2;HOXA9;NFKB2;ZBTB26;KLF2;HDGF;PNKP;ZBTB7A;NUCKS1;TEAD1;USF1;SREBF1;NFAT5;MAPT;SOX4;ZBTB32;IRF6;ZBP1;HOXA1;ELF1;KLF10;TERF2;MTF1;UBP1;YY1;YBX1;GABPA;ARNT;HOXA2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4671869856417975,0.9649907936917018,0.5187074829931972,0.9470666037016299,1.0,1/10,0.70%,SLCO2A1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4703618995143902,0.9649688692713605,0.5165876777251185,0.9435604616884451,1.0,3/10,10.85%,KDM4B;RIOX2;KDM4C
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.3882147756238534,-0.9636849477481076,0.5115089514066496,0.8274479492764056,1.0,4/11,16.11%,SLC35B3;LRRC8A;SLC25A25;SLC25A23
prerank,RNA cap binding (GO:0000339),0.4267050334656075,0.9630747586192356,0.5122324159021406,0.9445467864231285,1.0,1/16,0.78%,CYFIP2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.29724967209775516,0.9615322947990771,0.64,0.9448647853820062,1.0,125/830,14.33%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZNF436;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;CIC;SIX1;MAZ;JUN;POU3F1;TCF7L2;ZFP57;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZNF177;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,gamma-tubulin binding (GO:0043015),0.4036007621966597,0.961170059466759,0.5058139534883721,0.9423291891329455,1.0,7/22,18.91%,NDRG1;DIXDC1;RAB11FIP5;MARK4;BLOC1S2;GIT1;TUBGCP5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4122246615155708,-0.9563668398059747,0.5098039215686274,0.8386213698740432,1.0,3/10,8.63%,SLC6A13;SLC6A12;SLC6A1
prerank,death receptor binding (GO:0005123),0.42816042119565967,0.9563602154804993,0.5101404056162246,0.9506730139749856,1.0,3/15,10.98%,EDA;NGF;FEM1B
prerank,neurexin family protein binding (GO:0042043),0.4682444538120502,0.9548665406040058,0.532695374800638,0.9507641244951323,1.0,2/10,7.06%,SYTL4;CPE
prerank,dynactin binding (GO:0034452),0.43733708073041544,0.9546898972400454,0.5234113712374582,0.9477181028408884,1.0,4/12,20.09%,PAFAH1B1;GSK3B;HOOK3;MAPT
prerank,anion channel activity (GO:0005253),0.3393869280926455,0.9546833487980599,0.54632972322503,0.9442774042010931,1.0,12/61,15.05%,CFTR;ANO7;VDAC2;CLIC1;CLCN4;SLC1A4;ANO6;VDAC1;ANO3;CLCC1;GPR89B;GPR89A
prerank,cytochrome-c oxidase activity (GO:0004129),0.43616491365137156,0.9539332483084002,0.5231481481481481,0.9427291988260216,1.0,4/15,10.26%,COX5A;COX8A;COX7A2L;COX5B
prerank,rRNA binding (GO:0019843),0.35975542681497963,0.9539248577555304,0.5189542483660131,0.9393459046852262,1.0,7/42,15.50%,PPAN;MRPS7;UTP23;ANG;MRPS27;MDM2;MRPS18C
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3124158192340256,0.9537141020491707,0.5573770491803278,0.9364281224812188,1.0,24/134,15.33%,CFTR;SLCO2A1;SLC36A3;SLC35D3;SLC16A11;SLC66A1;OCA2;CTNS;SFXN3;SLC36A4;SLC3A1;SLC2A8;SLC25A1;SFXN1;SLC25A38;SLC1A4;SLC25A17;SLC25A21;PDPN;SLC26A4;SLC6A7;SLC19A2;SLC25A12;SLC7A3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3059617071468024,0.9536162937160589,0.5582120582120582,0.9332883574610448,1.0,36/181,15.63%,KLF4;PPARGC1A;NCOA3;EP300;HDAC5;FOS;HDAC4;NFE2L2;ANXA4;WWP2;HSPB1;MTDH;SMARCB1;NFKBIA;CREB1;DDRGK1;COMMD7;FIZ1;JUN;TCF7L2;FOXP3;ACTB;BCAS3;HDAC3;COMMD6;SMARCA4;NCOR1;SP1;MIER2;PIAS1;PIAS3;MKKS;GSK3B;NCOR2;DHX9;ACTN4
prerank,histone demethylase activity (GO:0032452),0.3886187443974337,0.9514473682606733,0.52046783625731,0.934895672073645,1.0,7/27,12.09%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,retinoic acid receptor binding (GO:0042974),-0.3358201172452188,-0.9514289227086512,0.5102040816326531,0.8445752185605949,1.0,3/17,9.23%,TACC1;NSD1;PPARG
prerank,protein phosphatase binding (GO:0019903),0.31262527889916414,0.9507120167584564,0.5557986870897156,0.9331780237593686,1.0,22/117,12.95%,MAP3K5;ANK1;GTF2F1;IKBKE;PPP6R3;SH3RF2;AP3B1;PPP1R15A;ROS1;PXN;SMG7;BAD;LGALS3;IQGAP1;PPP1R16A;MTMR3;PPP1R11;AKAP5;JAK1;MVP;EIF2AK3;ANAPC4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4035124772256398,0.9493816469045313,0.5278174037089871,0.9297158684710733,1.0,6/21,13.17%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4035124772256398,0.9493816469045313,0.5278174037089871,0.9297158684710733,1.0,6/21,13.17%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.26586866632489975,-0.9492312321246842,0.52,0.8435358391759058,1.0,7/44,10.14%,MECOM;SETD5;PRDM16;NSD1;EZH2;RBBP5;NSD3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3731262762231421,-0.9466887908217384,0.5216284987277354,0.8428780086453735,1.0,5/12,21.07%,SLC35B3;LRRC8A;SLC25A25;SLC25A23;SLC25A5
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3952397552285543,0.9462608524537296,0.5207439198855508,0.9272696092807072,1.0,1/22,0.76%,CHRM1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3952397552285543,0.9462608524537296,0.5207439198855508,0.9272696092807072,1.0,1/22,0.76%,CHRM1
prerank,serotonin receptor activity (GO:0099589),0.3952397552285543,0.9462608524537296,0.5207439198855508,0.9272696092807072,1.0,1/22,0.76%,CHRM1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.4306228246975362,0.9458858931596407,0.5273865414710485,0.9248436097735582,1.0,1/12,0.98%,CNOT6
prerank,MAP-kinase scaffold activity (GO:0005078),-0.39782118725535853,-0.9456816621662782,0.5333333333333333,0.8387868483684512,1.0,2/11,0.54%,SH3RF1;KSR1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.42966050466215616,0.94546410805688,0.5433436532507739,0.9226560264541696,1.0,4/15,7.98%,VEPH1;PHLDA3;RUBCNL;JPH2
prerank,protein heterodimerization activity (GO:0046982),0.3066386423794087,0.9453586980914418,0.5851619644723093,0.9196799989910912,1.0,26/178,14.72%,ADRA1B;AGTR1;HEXA;ATP1A2;PGLYRP3;PEF1;PPP2CA;BUD23;BCL2L1;ADD1;PSMF1;MICU1;ERBB3;TLR6;EXT1;KCNB1;PAFAH1B1;TLR4;SAE1;GABBR2;FXR1;TUBB2B;IRAK1;MEF2C;CHUK;SDCBP2
prerank,I-SMAD binding (GO:0070411),0.43397177232453776,0.9442888150862154,0.532258064516129,0.9190893231155872,1.0,2/13,7.67%,SMAD6;TGFB1I1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.29646461427291826,0.9430327947937694,0.5942622950819673,0.9186979625948146,1.0,48/232,17.78%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;NSMCE2;RNF126;PIAS1;PIAS3;DTX3;PELI1;CBX4;VPS18;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,SH2 domain binding (GO:0042169),-0.28996552592902386,-0.9427394918144163,0.5205992509363296,0.8393172887730529,1.0,11/31,18.47%,AFAP1L2;SH3PXD2B;PTK2;PAG1;JAK2;BLNK;RACK1;RUFY1;SKAP1;SH2B2;INPPL1
prerank,ATP binding (GO:0005524),0.2953535811771218,0.942421362990979,0.6174974567650051,0.9168551311644005,1.0,84/266,22.52%,PRAG1;MAP3K5;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,sequence-specific DNA binding (GO:0043565),0.2922391656493112,0.9424146771405396,0.6609829488465396,0.9137254218293245,1.0,71/590,12.94%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PPARGC1A;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;FOXD1;ZBTB7B;MEF2D;UPF3A;SMG7;SIX1;JUN;POU3F1;TCF7L2;CXXC4;GRHL2;FOXP3;KMT2A;NR2C1;ZIC1;NFIB;NFIC;SP2;CREB3L4;CREB3;CALCOCO1;MEF2B;MMP12;HOXB5;MAFG;SP1;ZNF148;MAFK;FOXK1;TFEB;GATA3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.28926924724175407,-0.9398118802544289,0.5306859205776173,0.8401422561890588,1.0,7/30,12.48%,SLC30A10;SLC39A12;SLC40A1;SLC39A8;SLC39A10;TTYH1;SLC30A1
prerank,tau protein binding (GO:0048156),0.35385267365564077,0.9396892169699704,0.5416666666666666,0.9170347663405123,1.0,12/40,18.79%,CLU;EP300;PPP2CA;ACTB;MARK4;GSK3A;GSK3B;PPP2CB;HSP90AA1;STUB1;HDAC6;ROCK2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.41987322525900184,0.937750555662269,0.5319148936170213,0.9183416854709121,1.0,4/16,17.46%,ALOX5;TDO2;CDO1;HAAO
prerank,thyroid hormone receptor binding (GO:0046966),0.3784397355104469,0.9324634835816978,0.5401662049861495,0.9268422654706064,1.0,6/28,13.64%,NCOA3;MED30;GAS2L1;NCOR1;MED12;MED24
prerank,pyrophosphatase activity (GO:0016462),-0.2555323502784939,-0.9290334264142978,0.6067961165048543,0.859914189779477,1.0,20/50,23.19%,ENPP1;ENTPD1;ALPL;PPA1;ITPA;ENPP3;LHPP;PRUNE1;PPA2;ATCAY;PRUNE2;DHX29;DOLPP1;NUDT1;ENTPD3;ENTPD5;ENTPD6;CILP;FITM2;NUDT16
prerank,translation initiation factor activity (GO:0003743),0.3574017236427792,0.9289812191567212,0.5531914893617021,0.9314597266107684,1.0,13/36,17.43%,EIF3L;EIF2B2;EIF3K;EIF4G2;COPS5;EIF3M;EIF4G1;EIF4A1;EIF5B;EIF3B;EIF1;EIF2B4;EIF4A2
prerank,myosin binding (GO:0017022),0.332409333575212,0.9287527102936828,0.564134495641345,0.9288452503486193,1.0,10/55,13.55%,CALD1;GSN;CXCR4;MLPH;NCKIPSD;RAB3B;LMTK2;LLGL2;RHOA;ARFGEF1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.297317570727085,0.9279399678081395,0.6183524504692388,0.9275149898359055,1.0,29/188,12.94%,BNC2;KLF4;PBX1;SMAD6;GABPB1;GABPB2;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;JUND;SIX1;JUN;TCF7L2;CRY2;BRD7;NFYC;ARID4A;NCOR1;CALCOCO1;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3
prerank,motor activity (GO:0003774),0.33349417839579587,0.9216869695151987,0.5608272506082725,0.937970794462708,1.0,6/60,6.66%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.39056272560644767,0.921533604789499,0.568081991215227,0.9351587812651716,1.0,5/22,15.90%,CPEB2;ZC3H12A;RBMS3;CPEB3;MEX3D
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3182192453638901,0.9199354541569562,0.5803048065650644,0.9354939631114852,1.0,23/71,18.00%,PTPN14;EYA2;PTPRU;PTPRD;DUSP1;PTPRF;EYA1;PTPN9;PTPRA;PTPN6;MTMR3;ACP1;PTPRE;PTPN2;PGP;PTP4A3;DUSP11;PTPDC1;CDC25B;PTPN13;PTP4A2;DUSP3;PTPN11
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.31774856525845263,0.9179942178147249,0.5794504181600956,0.936534100866394,1.0,13/74,10.63%,FAM20C;ADK;PIK3C2B;AGK;PKM;NT5C3A;NADK2;DCAKD;TRPT1;NADK;PI4KA;HK1;DGKA
prerank,GTPase activity (GO:0003924),0.29505259301574316,0.9170547720616152,0.6478578892371996,0.9354889094675282,1.0,46/192,19.24%,RAB17;MRAS;RAP1B;EEF1A1;RAP1A;RHOQ;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;BMS1;RAB35;GNAO1;AGAP3;GNAQ;GNA13;RHOA;RABL3;OPA1;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;ARHGDIB;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;HBS1L;RNF112;RAB27A;RAB9A;RHOT2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.42731110728777977,0.9146447370282961,0.5564142194744977,0.9375972446844918,1.0,3/13,6.80%,GDF15;BMP5;BMP4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.31280142568674874,0.9142950103218481,0.5981735159817352,0.935275484570138,1.0,16/91,10.88%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,filamin binding (GO:0031005),0.43139212418838263,0.9137449539011836,0.5774647887323944,0.9333844120831514,1.0,1/11,1.59%,NEBL
prerank,ubiquitin protein ligase activity (GO:0061630),0.2863520830225841,0.9088005839630644,0.6526207605344296,0.941076621005374,1.0,45/228,17.78%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;RNF126;DTX3;PELI1;VPS18;UBE4A;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,ligand-gated cation channel activity (GO:0099094),-0.2327534172056384,-0.9080569317996654,0.6742424242424242,0.9035863427054797,1.0,15/75,14.60%,GRIK2;KCNN2;GRIN2A;GRIA3;GRIA2;GRIN2B;KCNJ2;GRIK3;MCOLN1;GRIK1;GRIK4;KCNJ12;CCDC51;KCNJ6;KCNJ10
prerank,ATPase binding (GO:0051117),0.31371630226118286,0.9078884665693467,0.6071856287425149,0.9399078691119214,1.0,13/71,14.48%,ANK2;ANK1;PEX26;BBC3;CAV1;PIH1D1;CHMP4A;EZR;ATP5IF1;S100A1;TOR1AIP1;DNAJC10;ATP6V1E1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.30082371544735137,-0.9062324909043223,0.597444089456869,0.9013947017212408,1.0,10/24,25.53%,KCNN2;ABCC9;KCNJ2;KCNJ12;KCNJ6;KCNJ10;KCNJ8;KCNJ15;KCNK1;KCNJ3
prerank,mannose binding (GO:0005537),-0.35699278634348486,-0.9058308324178349,0.5714285714285714,0.8954932639854565,1.0,2/12,12.44%,LMAN2L;LMAN2
prerank,snoRNA binding (GO:0030515),0.3582032696917683,0.9055148156687738,0.5743801652892562,0.9418681330536157,1.0,6/30,18.25%,NUDT4;BMS1;GAR1;RRP9;IMP4;IMP3
prerank,phosphotyrosine residue binding (GO:0001784),-0.2663167798741961,-0.9052682164711428,0.6171875,0.890261610912009,1.0,10/37,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,histone deacetylase binding (GO:0042826),0.30618581706464126,0.9035173646528883,0.5997693194925029,0.943033899272452,1.0,20/88,17.34%,GLI3;HDAC5;HDAC4;NACC1;LCOR;MEF2D;YWHAB;FOXP3;CCND1;HDAC3;SP2;NCOR1;MEF2B;SP1;MIER2;MEF2C;NCOR2;HSP90AA1;CAMTA2;HDAC6
prerank,metal ion binding (GO:0046872),0.28122002111235445,0.9016173274975273,0.7427427427427428,0.9439270663068803,1.0,56/477,11.72%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;MAP3K5;TSSK6;TSSK4;ANXA8;ANXA8L1;GSN;S100A6;FEN1;EYA2;S100A10;OTOF;IDH3G;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;RHEB;NT5C3A;SIK3;ANXA2;DCTPP1;MICU1;DSC3;DSC2;LATS1;HPGDS;CETN3;IQGAP1;OXSR1;CALR3;CHP1;PCLO;TRIM26;MOV10L1;PCDHA4;THG1L;ITPR3;DNASE1L2;SRPK2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4
prerank,alpha-actinin binding (GO:0051393),0.37026712335666034,0.9013786411894074,0.5817091454272864,0.9414333480268384,1.0,10/24,18.63%,PDLIM5;DAG1;MYOT;PKD2L1;KCNA5;PDLIM7;NRAP;PDLIM3;RARA;PDLIM4
prerank,ATPase regulator activity (GO:0060590),-0.26252058125390915,-0.9003246537024834,0.639344262295082,0.8954866136582915,1.0,16/38,24.18%,TSC1;ATP1B1;DNAJB4;FNIP1;DNAJA1;DNAJC19;FNIP2;BAG4;DNAJB2;BAG5;BRSK2;GRPEL1;DNAJC1;BAG2;DNAJB1;AHSA1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3207894088238833,0.8996711274500476,0.6092636579572447,0.9419863468845454,1.0,13/69,13.91%,SOAT1;EP300;DGAT1;MOGAT3;ZDHHC12;MOGAT1;KAT6B;SOAT2;CERS2;MBOAT7;NAA15;LPCAT3;NAA10
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.4217565661142504,0.8994233627711614,0.5872,0.9395368372087523,1.0,8/12,26.83%,SDHB;FDX1;ISCA1;CIAPIN1;ISCA2;AOX1;CISD2;CISD1
prerank,kinase binding (GO:0019900),0.2795362703677773,0.8975319599374011,0.7560240963855421,0.9405559020153125,1.0,107/435,20.09%,MYOM2;UTRN;ANK2;DAXX;PIK3IP1;CDKN1A;ADAM10;EMP2;GSN;CAV1;MAVS;NBEAL2;EEF1A1;QARS1;FOXO3;RELB;AP2A2;HSPB1;PPP1R15A;PIH1D1;CAV2;BCL2L1;POLR2A;RNF138;FOXM1;SPRED3;SHC1;PFKFB2;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CHP1;CDK5RAP1;ACTB;PTPN6;CCND1;SMCR8;ZC3HC1;CARD16;EXOC2;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;MAP3K13;VDAC1;IRAK1;SHC2;GSK3B;WNK1;DNAJC3;TNNI3;RB1CC1;ITGB2;FLNA;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;PRKAG1;NSF;CDC25B;STUB1;MTCP1;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;PARK7;ATF2;MOB1B;CDKN2D;CAB39;CDK5RAP3;IRAK4;SIKE1;TOM1L2;MAP3K1;RB1;PRKAB1;USF1;MAPT
prerank,BMP receptor binding (GO:0070700),0.42731536793851577,0.8975042230620035,0.5899053627760252,0.9376328982014208,1.0,3/12,6.80%,GDF15;BMP5;BMP4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.34957463786802967,0.8965124521361665,0.5938748335552596,0.9367588759560314,1.0,7/32,13.71%,SLC36A3;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;SLC6A7
prerank,U6 snRNA binding (GO:0017070),0.40721384734683014,0.8960371968515319,0.5831960461285008,0.9346721095364577,1.0,5/14,21.20%,LARP7;LSM4;DDX39B;TUT1;PRPF8
prerank,protein phosphatase 1 binding (GO:0008157),0.3703273294180356,0.8949327458871739,0.5863095238095238,0.9340370495509043,1.0,4/21,10.20%,SH3RF2;PPP1R15A;PPP1R16A;PPP1R11
prerank,adenyl ribonucleotide binding (GO:0032559),0.2800690747070498,0.8949315504527522,0.7276422764227642,0.9311212879432681,1.0,91/291,22.83%,PRAG1;MAP3K5;MPPED2;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HMGCR;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;SLC19A1;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;MIEF1;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1;APRT;ABCB8
prerank,sodium channel activity (GO:0005272),0.33853064982703307,0.8949193542355266,0.5921052631578947,0.9282391655840815,1.0,2/37,1.20%,ASIC5;SCN3A
prerank,5'-3' RNA polymerase activity (GO:0034062),0.359725858876618,0.8948995061965227,0.5900962861072903,0.9254027086307482,1.0,9/27,18.69%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,muscle alpha-actinin binding (GO:0051371),0.39476900680975757,0.8940514009712129,0.5801282051282052,0.9242444989588273,1.0,7/15,20.68%,PDLIM5;PKD2L1;PDLIM7;NRAP;PDLIM3;PDLIM4;MYPN
prerank,microtubule plus-end binding (GO:0051010),0.3847153525193421,0.893126944365713,0.5968436154949784,0.9232283360895882,1.0,3/20,10.55%,MAPRE2;CLIP4;PAFAH1B1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.43740263538487556,0.8912439581107598,0.5755517826825127,0.9242631686436749,1.0,3/10,18.86%,CDKN1A;HEXIM1;CDKN2D
prerank,phosphatidylinositol binding (GO:0035091),0.3055380473412684,0.889472501440831,0.6523754345307068,0.9248406905811924,1.0,16/91,14.67%,PITPNM2;ITPR2;PIGU;SNX8;PITPNC1;RUBCNL;WDFY3;GPAA1;RUBCN;ITPR3;BCAS3;SNX12;ESYT2;EXOC8;CCDC88A;SNX16
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.28558718801039806,0.8894487476552181,0.6635021097046413,0.9220853369175719,1.0,28/173,14.16%,TFAP2C;SREBF2;RORC;FOXP2;KLF12;FOXP4;ZNF436;ZNF692;FOXO3;ZNF219;ZBTB16;NACC1;OVOL2;PATZ1;ZBTB17;CC2D1A;ZFHX3;JUN;ZFP57;FOXP3;SP2;ZNF148;MAFK;FOXK1;GATA3;MYC;ZNF177;FOXP1
prerank,tau-protein kinase activity (GO:0050321),-0.30509951548961634,-0.8881904491650483,0.6170886075949367,0.9178060842011926,1.0,4/20,7.58%,MARK1;BRSK1;PRKAA1;ROCK1
prerank,cation channel activity (GO:0005261),0.2998675723110124,0.8876406616174751,0.6362625139043382,0.9226084363575613,1.0,18/94,15.70%,TRPM3;NALCN;TRPM8;MCU;CALHM5;ABCC8;ANXA2;PKD1;TRPM6;AQP1;TRPM4;PKD2L1;ANO6;CACNB2;TRPM2;TMEM175;HVCN1;TMEM63B
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3582193586461969,-0.8862010905819412,0.5903614457831325,0.9157518655187917,1.0,1/11,2.67%,CXCL12
prerank,transcription coactivator binding (GO:0001223),0.3659127272600686,0.8850678321991075,0.5806451612903226,0.9250546409636096,1.0,2/20,6.14%,THRB;ZBTB17
prerank,ion channel activity (GO:0005216),0.30820150557135706,0.884266691051099,0.6517754868270332,0.9240153674241116,1.0,13/80,13.38%,TRPM3;NALCN;TRPM8;TMC6;MCUB;CALHM5;GRID1;TMC2;TRPM6;TRPM4;PKD2L1;CNGB1;TRPM2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.27370107780513037,0.8801083268705078,0.7655935613682092,0.9291914681573158,1.0,121/431,22.52%,PRAG1;MAP3K5;TSSK6;TSSK4;MRAS;RAP1B;ABCD1;ATP1A2;EEF1A1;CDK6;RAP1A;MKNK2;ARL4A;DAPK3;DAPK1;ARL3;HARS1;RHOQ;PFKP;CARS2;TWF1;PMVK;EIF2B2;NRAS;KRAS;RHEB;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;CDC42;RAB7A;HSPA14;ARHGEF5;LMTK2;MOV10L1;GTPBP10;THG1L;AARS1;AK6;BMS1;RAB35;SRPK2;MTREX;ABCA2;PDK2;ARFIP2;RHOA;RABL3;MARK4;SRPK1;OLA1;ARF4;RHOU;TARS1;TUBB2B;VPS4A;SARS2;RAB1B;HRAS;EIF4G1;TRNT1;WNK1;ATL2;CDC42BPA;ABCB9;DHX9;HSP90AA1;RAP2C;OAS2;ARL8A;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;ADSS2;PRKAG1;DIRAS2;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;RNF112;DARS2;ABCB6;RAB27A;RAB9A;RHOT2;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;RAB10;ATP1A3;ATP1A1;WNK4;YARS2;RABL6;RHOC;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,Tat protein binding (GO:0030957),0.425622114054672,0.8793612682874693,0.5908346972176759,0.9278198698984808,1.0,3/10,11.01%,SMARCB1;ACTB;SMARCA4
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3548992233336344,0.8790090966333215,0.6121045392022009,0.9256779495179922,1.0,9/27,18.69%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,peptidase activator activity (GO:0016504),0.3601186447533086,0.8778925302604919,0.6050295857988166,0.9250269614402962,1.0,2/22,5.01%,CAV1;PCOLCE2
prerank,endopeptidase activator activity (GO:0061133),-0.3610107367331381,-0.8772853362871036,0.5971563981042654,0.9297007331961212,1.0,5/10,33.21%,PSME1;APH1B;VSIR;PSME2;NLRC4
prerank,NADP binding (GO:0050661),0.3447202420365205,0.8756769722075991,0.6243386243386243,0.9264732765326636,1.0,5/32,8.16%,DHCR7;HMGCR;ME3;CRYZL1;PGD
prerank,tRNA methyltransferase activity (GO:0008175),-0.32243738538438743,-0.8753141723056409,0.6468842729970327,0.927793153445692,1.0,8/16,24.67%,TARBP1;THUMPD2;TRMT5;TRMT9B;TRMT44;ALKBH8;TYW3;BCDIN3D
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.40145805417124564,0.8728022871937344,0.6019261637239165,0.9294246361035958,1.0,5/14,21.39%,SDHB;ACO2;CIAO3;ISCA2;ACO1
prerank,mechanosensitive ion channel activity (GO:0008381),0.4128792193882317,0.8724083988159324,0.6221864951768489,0.9274094901420473,1.0,4/12,20.99%,TMC6;TMC2;TMEM63B;TMC4
prerank,AMP binding (GO:0016208),0.4167462074377386,0.8709877866847318,0.6235679214402619,0.9273194668042637,1.0,2/11,5.22%,MPPED2;PFKP
prerank,ephrin receptor binding (GO:0046875),0.3588610468507829,0.8696289831318765,0.6171516079632465,0.9271449990079592,1.0,6/21,16.81%,EFNB2;EFNA5;SHC1;EFNA4;CRK;ABL1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.367058813698761,-0.8692420896362706,0.6289156626506024,0.9348176478797402,1.0,4/10,14.80%,PIK3CB;PIK3CD;PIK3R3;PIK3C3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2944238786814226,0.8685067854269836,0.6774916013437849,0.9265683803021637,1.0,14/100,8.44%,ARAP1;OGT;VEPH1;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;RUBCNL;GOLPH3;ZFYVE19;JPH2;RUBCN;IQGAP1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.32833784499890495,-0.8683880430124804,0.650990099009901,0.9302992661000702,1.0,3/14,12.35%,NOD1;MAL;RACK1
prerank,cyclic nucleotide binding (GO:0030551),0.36436294981115797,0.8675221255482821,0.6253602305475504,0.9256426697764785,1.0,3/21,7.34%,PDE5A;CNGA2;CNGB3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4027589871230553,0.8659487173102214,0.631911532385466,0.92604681957249,1.0,3/14,18.59%,CAPN2;CAPNS1;CAPN15
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29129700982507456,-0.8658429528422699,0.6632302405498282,0.9294084863551045,1.0,6/24,12.00%,PLA2G4A;DAB2IP;PLEKHA8;GSDMD;LANCL2;PLEKHF1
prerank,chemokine receptor binding (GO:0042379),0.3307415852424398,0.8656593967892968,0.6180081855388813,0.9239377628446026,1.0,2/35,5.94%,CCL5;CCRL2
prerank,chloride channel activity (GO:0005254),0.3071524021620579,0.8646130414910851,0.643719806763285,0.9231548270100792,1.0,9/59,15.63%,CFTR;ANO7;CLIC1;CLCN4;SLC1A4;ANO6;ANO3;CLCC1;PACC1
prerank,transcription cis-regulatory region binding (GO:0000976),0.27019160070929615,0.8626147554084269,0.8132530120481928,0.924314153201472,1.0,65/406,16.70%,BNC2;FOXN3;KLF4;TFAP2C;PBX1;TFAP2D;SMAD6;GLI3;GABPB1;GABPB2;ZNF436;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;ZBTB8A;ESRRB;JUND;ZBTB46;FOXM1;ZBTB17;RXRB;ZBTB7B;MEF2D;CIC;SIX1;JUN;TCF7L2;CRY2;ZFP57;XRN2;GRHL2;BRD7;NFYC;TWIST1;ARID4A;CREB3;NCOR1;DR1;CALCOCO1;MMP12;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;RREB1;MYC;ZNF177;MEF2C;FOXP1;IRF2;ATMIN;RFXAP;ZFP3;ACTN4;CDC5L;CREB3L2;RNF10;E2F1;HINFP
prerank,NAD+ binding (GO:0070403),-0.3451176511360874,-0.8624212691461542,0.6145552560646901,0.9308294106510823,1.0,3/12,15.80%,ZC3HAV1;HPGD;SIRT2
prerank,MHC class II protein complex binding (GO:0023026),0.4119794106479371,0.8608368552641582,0.6126984126984127,0.9250361414781514,1.0,2/11,6.07%,CD81;PKM
prerank,magnesium ion binding (GO:0000287),0.28249404953900054,0.8600043001805625,0.7054347826086956,0.9238216883310835,1.0,28/135,16.92%,MAP3K5;TSSK6;TSSK4;FEN1;EYA2;IDH3G;RHEB;NT5C3A;SIK3;DCTPP1;LATS1;HPGDS;OXSR1;MOV10L1;THG1L;SRPK2;PLSCR3;SRPK1;OPA1;PGP;ENDOV;CDC42BPA;FAN1;IDH3A;PI4K2A;ABL1;YDJC;MAP3K6
prerank,fatty acid synthase activity (GO:0004312),0.4114559887618313,0.8589618308460995,0.63,0.922988142670688,1.0,2/10,8.12%,ELOVL1;ELOVL6
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3561007431284935,0.8580244807319696,0.6454005934718101,0.9221650662410535,1.0,5/21,14.42%,REV1;POLK;POLG;POLE4;POLH
prerank,mRNA 5'-UTR binding (GO:0048027),0.3561413661341,0.8577919494388813,0.6523605150214592,0.9199758906571073,1.0,11/24,28.53%,UTP23;SHMT1;SYNCRIP;IGF2BP3;IGF2BP2;RPL41;IGF2BP1;RPL26;CCT5;LARP1;DDX3X
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4037875721826772,0.8554410979120058,0.6331168831168831,0.9215121680989753,1.0,2/12,7.81%,ARSI;ARSB
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4071380767074836,0.8542288729545683,0.6323296354992076,0.9211997891632846,1.0,2/12,5.41%,CDK6;CDK4
prerank,cysteine-type peptidase activity (GO:0008234),0.2987194033436329,0.853842419613917,0.6904474002418379,0.919307723053428,1.0,27/73,24.44%,TINAGL1;USP46;USP29;USP10;CTSZ;OTUD7B;CAPN2;USP20;USP24;USP42;SFRP1;USP28;CTSH;ATG4B;USP25;OTULIN;USP16;USP21;CTSK;USP2;USP11;BLMH;CASP3;ATG4D;USP13;USP34;CTSF
prerank,nucleotidyltransferase activity (GO:0016779),0.36432306005846804,0.8511474973980985,0.6470588235294118,0.9214305533573064,1.0,5/19,12.98%,MOCS3;REV1;TENT4A;THG1L;TUT7
prerank,cation:chloride symporter activity (GO:0015377),0.41566542332047185,0.8490055184865113,0.6467576791808873,0.9226656102830998,1.0,3/10,16.20%,SLC12A8;SLC12A4;SLC12A6
prerank,poly-purine tract binding (GO:0070717),0.34672702728379656,0.8489853509641497,0.6584302325581395,0.9201073361567109,1.0,4/27,6.95%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,clathrin adaptor activity (GO:0035615),-0.31613877970864634,-0.8432469012434958,0.6931818181818182,0.9657409130136057,1.0,4/15,12.53%,HIP1;DAB2;AP2B1;STON2
prerank,adenylyltransferase activity (GO:0070566),-0.2868541884693639,-0.8424155357384013,0.6542056074766355,0.9609345819155364,1.0,6/21,20.09%,GPHN;PAPOLA;PAPOLG;SELENOO;TENT2;PAPOLB
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3448038208420958,-0.8392065255373283,0.6743589743589744,0.9611727302562099,1.0,2/11,5.73%,SGMS1;PTDSS1
prerank,DNA-binding transcription factor binding (GO:0140297),0.26849223629240765,0.838931119346536,0.7740932642487046,0.9357216711593582,1.0,46/189,19.96%,KLF4;EP300;HDAC5;FOS;DAPK3;CGGBP1;HDAC4;NFE2L2;WWP2;HSPB1;MTDH;CREB1;ZBTB17;HCFC1;DDRGK1;MEF2D;FIZ1;JUN;TCF7L2;TWIST1;TLE2;PTMA;NCOR1;TLE4;YWHAZ;SP1;MIER2;PIAS1;PIAS3;MKKS;MYC;MEF2C;TLE5;GSK3B;DHX9;KDM1A;RERE;NBN;PARK7;ATF2;TLE6;ZBTB7A;RB1;TBP;USF1;DDX20
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3349591066501832,0.837315264370619,0.65814266487214,0.935893701261755,1.0,11/29,22.75%,DUSP10;DUSP1;MAPK7;PPM1D;TNIP1;ABL1;PRMT1;MAPKAPK2;CDK5RAP3;DUSP16;TPR
prerank,high voltage-gated calcium channel activity (GO:0008331),0.41009813836519965,0.8370214242773959,0.656,0.9338650476020957,1.0,2/10,3.47%,CACNA1A;CACNB3
prerank,DNA polymerase activity (GO:0034061),0.34476103631702765,0.8360449626646582,0.672082717872969,0.932937573594485,1.0,5/22,14.42%,REV1;POLK;POLG;POLE4;POLH
prerank,histone methyltransferase binding (GO:1990226),0.4000778323622887,0.8353119545874901,0.6596774193548387,0.9315997432068179,1.0,2/11,6.01%,PHF1;LCOR
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.33749233723775507,0.8326705272471476,0.6997319034852547,0.9334770630990177,1.0,6/28,14.48%,FEN1;POP4;POP1;DBR1;RPP21;ENDOV
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36590330433836527,0.8319390774813069,0.6894502228826151,0.9321560633220953,1.0,4/19,10.16%,CCL5;EFNA5;ERBB3;ABI1
prerank,store-operated calcium channel activity (GO:0015279),0.39572055531850575,0.8298235475614318,0.6463620981387479,0.9330036443270551,1.0,1/10,1.25%,STIM2
prerank,ribonuclease P RNA binding (GO:0033204),0.40587759076730234,0.829770654703061,0.6661211129296236,0.9305536071348938,1.0,3/10,12.35%,POP4;POP1;RPP21
prerank,GTPase regulator activity (GO:0030695),0.26420191400530463,0.8260462023894669,0.8068535825545171,0.9344542189868168,1.0,44/212,15.22%,ARHGAP42;SRGAP2;ARAP1;RANBP3L;ASAP2;CPEB2;SIPA1L1;ARHGAP18;WNT11;GRTP1;TBC1D16;ADAP1;IPO7;SH3BP4;TSC2;ARHGAP29;ARHGAP10;KRIT1;JUN;IQGAP1;BCR;RALGDS;OPHN1;LLGL2;DLC1;SGSM2;GNAQ;TBC1D1;RASA1;RGS6;DOCK1;ASAP3;ARHGEF10L;OCRL;ARHGAP31;ARFGEF1;PREB;CCDC88A;ARHGAP27;DNM1L;FLCN;ITGB1BP1;SEC23A;USP6NL
prerank,transforming growth factor beta receptor binding (GO:0005160),0.35202447863896363,0.8257584225585114,0.6717557251908397,0.9323086042099956,1.0,4/18,14.16%,SMAD6;TGFB2;TGFBR2;TGFBR3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2580073938541522,0.825284681645575,0.8520770010131712,0.9305201582464875,1.0,101/346,25.36%,RNF152;TRIM60;FBXW8;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;KLHL21;MUL1;CBLL1;TRIM41;TRIM21;MAGEL2;UBE2G2;RMND5B;RBX1;CDC42;RNF146;PML;TRIM47;TRIM26;TRIM11;RNF121;UBE2B;RNF182;LTN1;PPP1R11;SIAH3;COP1;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;RNF123;RNF141;ANAPC4;DTX3;PELI1;VPS18;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;MSL2;PRPF19;MAEA;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;UBE2J1;PDZRN3;TRIM37;RNF112;RNF41;RNF130;UBE2Z;UBE3C;FBXO9;RMND5A;ZFP91;CHFR;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;TRAF3IP2;SMURF2;RNF168;NSMCE1;RNF213;TRIM3;RNF14;RNF7;CDC23;FBXO4;UBR4;UBE3D;RNF150;BIRC3;UBA7;TMEM129;RING1;UBE2M;LRSAM1;TRIM39;TSPAN17
prerank,CARD domain binding (GO:0050700),-0.3090739568830966,-0.8232213843417749,0.7057356608478803,0.9877209837735529,1.0,4/14,11.65%,NOD1;CARD10;IRGM;CASP4
prerank,microtubule minus-end binding (GO:0051011),-0.324937226708483,-0.8228882251737718,0.6847826086956522,0.9818883951710706,1.0,7/13,29.33%,TUBGCP2;MACF1;CAMSAP2;HAUS4;HAUS7;TUBGCP3;CAMSAP3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3038523402652739,0.8191924526310551,0.7114178168130489,0.9382225067007222,1.0,11/49,15.27%,ANXA3;ANXA8;ANXA4;ANXA5;ANXA2;PCLO;ESYT2;CPNE2;SYT6;SYT11;SYT12
prerank,calcium channel activity (GO:0005262),0.2820165548812984,0.8175891214512093,0.7405714285714285,0.9384224687756613,1.0,14/84,13.38%,STIM2;CACNA2D3;CACNA1A;TRPM8;MCU;CACNB3;CACNA2D4;ANXA2;TMC2;PKD1;TRPM4;PKD2L1;CACNB2;TRPM2
prerank,vitamin D receptor binding (GO:0042809),0.37306267195996895,0.8163627167818805,0.6869009584664537,0.9379626994205,1.0,3/14,13.64%,MED30;MED12;MED24
prerank,ADP binding (GO:0043531),-0.268275629506038,-0.8158044370800512,0.7491961414790996,0.9896842921295,1.0,2/25,2.14%,PRKAG2;ME1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.24977203527596537,-0.815220424132886,0.75390625,0.9841629717286589,1.0,5/31,5.23%,KCNK5;ABCC9;PKD2;SLC12A2;KCNQ4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.29258953513802843,0.8146210972279923,0.7110834371108343,0.9384132888696993,1.0,23/54,30.46%,PDF;HDAC5;HDAC4;HDAC3;NIT1;MIER2;NTAQ1;VNN1;HDAC6;ACR;NADSYN1;SIRT4;SIRT7;NGLY1;HDAC8;PM20D1;SUDS3;NTAN1;ASRGL1;ASAH1;HINT3;HDAC11;FAAH
prerank,transcription coregulator binding (GO:0001221),0.2955549484351352,0.8125540743982824,0.7246558197747184,0.939335493520552,1.0,5/50,6.14%,THRB;ZBTB16;PHF1;LCOR;ZBTB17
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.30150640707905185,-0.8124703568114243,0.7357954545454546,0.9826469912337542,1.0,9/16,38.89%,SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;SLC7A8
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2848309635648355,-0.8116203826053819,0.7315068493150685,0.9781473715772901,1.0,5/17,26.86%,SLC2A1;SLC5A3;SLC5A11;SLC2A3;SLC2A4
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3200921356392006,-0.8100047842402455,0.7474747474747475,0.9749387406986912,1.0,4/12,26.86%,SLC2A1;SLC5A3;SLC2A3;SLC2A4
prerank,CoA-ligase activity (GO:0016405),-0.308577905043145,-0.8079051083750645,0.7272727272727273,0.9726444027844497,1.0,4/14,16.94%,ACSS3;ACSL1;ACSS1;ACSBG1
prerank,DNA binding (GO:0003677),0.25098562150050907,0.8075713730090538,0.9479479479479479,0.9449432206054829,1.0,164/694,22.45%,NFATC2;THRB;TFAP2C;PPARGC1A;PBX1;ZIC4;FOXP2;NUPR1;ZC3H12A;KLF12;FEN1;SLPI;EP300;MLH1;FOXO3;FOXC2;ZNF219;CGGBP1;SHOC1;HDAC4;NFE2L2;NR6A1;ZBTB16;ZMYM6;POLR2H;SMARCB1;FOXD2;POU2F3;NABP2;ESRRB;RARG;IRF3;SLTM;NKX2-8;PATZ1;PHF1;POLR2A;RNF138;HOXA5;SYCP2;MRE11;FOXD1;ZIC2;CENPS;ANG;TSNAX;SIX1;JUN;POU3F1;TCF7L2;CRY2;GRHL2;FOXP3;SDE2;NR2C1;TRIM26;DNMT3A;HDGFL3;ILF2;NFIB;POLG;DNASE1L2;NFYC;CR2;ARID4A;SMARCA4;ARID3B;JRKL;GTF3C3;CALCOCO1;MMP12;SP1;ZNF148;MAFK;ZMYM4;ERCC5;CHD3;GATA3;HMGN1;MBD4;MYC;POLR3C;RPA3;DNASE1L1;REXO4;PAX3;SRRT;IRF2;ENDOV;DNTTIP1;APTX;DHX9;TET1;MCM8;HMBOX1;PCNA;FAN1;CDC5L;ZGPAT;DCLRE1C;GTF3C2;DDB1;MCM6;E2F1;POU4F1;HINFP;ERCC2;SPTY2D1;ABL1;CAMTA2;SMC6;NBN;BCLAF3;MCM7;GTF3C5;TRIM16;TSG101;PLAGL2;MEOX2;RAD50;PARK7;RFC1;ZKSCAN3;RPL6;JCHAIN;APP;KLF2;HDGF;PNKP;ZBTB7A;PCBP2;NUCKS1;ERCC4;TEAD1;USF1;SREBF1;MAPT;IKZF1;NABP1;ZBTB32;ZNF513;IRF6;ZBP1;HOXA1;SNAPC3;ACR;TWNK;ZNF8;MTF1;YY1;SFPQ;TAF6;YBX1;MCM4;ZBTB49;ARNT;LONP1;PGR;MEN1;GTF3C4;RPL7;POLR3F;TFAM;IGHMBP2
prerank,chemokine activity (GO:0008009),0.3111091392771506,0.8058475523003649,0.7030386740331491,0.9452682837647605,1.0,1/31,1.51%,CCL5
prerank,voltage-gated calcium channel activity (GO:0005245),0.30848326015695293,0.8046743556721851,0.7307692307692307,0.9447488681326144,1.0,5/37,7.72%,CACNA2D3;CACNA1A;CACNB3;CACNA2D4;TMC2
prerank,acid-thiol ligase activity (GO:0016878),-0.3128431501644452,-0.8009073354112319,0.7180156657963447,0.9791847355560773,1.0,3/13,10.90%,ACSS3;ACSL1;ACSS1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34821104511971585,0.8008286241234669,0.705607476635514,0.9485849655738608,1.0,4/17,16.63%,CMPK1;AK3;AK5;CLP1
prerank,WW domain binding (GO:0050699),0.32226603767771844,0.800415219453888,0.7248968363136176,0.946724565589604,1.0,7/26,20.66%,ENAH;WBP1;TCEAL5;TCEAL8;KIF20B;TRAF4;PMEPA1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.36376231032065337,0.7981836458951754,0.7043618739903069,0.947835641782964,1.0,1/14,2.95%,ADH7
prerank,MAP kinase activity (GO:0004707),-0.29991037607857984,-0.7980665297721982,0.7209944751381215,0.9782050234282222,1.0,2/14,4.32%,MAPK4;MAPK10
prerank,3'-5' exonuclease activity (GO:0008408),0.2967606138814787,0.797155790598218,0.7235668789808917,0.9469176034355219,1.0,6/45,10.29%,CNOT6;MRE11;XRN2;EXOSC3;ERI3;POLG
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3662687661935503,0.7963729754646884,0.6981424148606811,0.9456576294119962,1.0,5/14,21.56%,POP4;POP1;RPP21;TSEN2;RPP40
prerank,signal sequence binding (GO:0005048),0.3101157133886226,0.7943790775744122,0.7540106951871658,0.9463883219721985,1.0,10/35,17.56%,KPNA7;NFKBIA;TNPO2;KPNA4;TOMM20;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27338664382413336,0.7930724435543407,0.7790304396843292,0.9460466504348439,1.0,7/85,11.29%,PLB1;ABHD5;ABHD15;PLA2G12A;PAFAH2;AARS1;PON3
prerank,hexosaminidase activity (GO:0015929),0.367808299436753,0.7927232961419879,0.6952380952380952,0.9442245162061911,1.0,4/12,16.25%,HEXA;HEXB;NAGA;HEXD
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.32203783312892126,0.7923890171603009,0.7065868263473054,0.9422828430504941,1.0,13/22,31.10%,ATP6V1E1;ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP2C1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.25033927109603527,0.790900510170053,0.8549540347293156,0.9422709920098817,1.0,42/254,15.86%,KLF5;KLF4;TFAP2C;ELF3;FOXO3;FOXC2;GLIS2;ZBTB16;FOXD2;POU2F3;ESRRB;IRF3;NKX2-8;CREB1;HOXA5;ZBTB17;RXRB;NRF1;KLF7;SIX1;JUN;GRHL2;PRDM15;NFIB;NFYC;NFIC;CREB3;MEF2B;SP1;GATA3;SMARCD2;RREB1;NFIA;MYC;MEF2C;MYBL1;IRF2;ATMIN;RFXAP;MDM2;KLF6;CDC5L
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.35668318919548514,0.7892064471524003,0.6788553259141494,0.9422848697887917,1.0,2/13,11.94%,ABHD5;LPCAT2
prerank,glutathione transferase activity (GO:0004364),0.3265127987256591,0.7867666693877893,0.7384615384615385,0.9435608260532282,1.0,5/23,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,growth factor activity (GO:0008083),-0.20263664803163237,-0.7843139966319255,0.9083969465648855,0.9955540076960225,1.0,7/74,8.71%,TGFA;JAG1;NRG3;VEGFC;FGF2;IGF2;JAG2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.28661288066225327,0.7832204973625555,0.7647783251231527,0.9468245530280534,1.0,13/53,15.33%,SLC36A3;SLC66A1;OCA2;CTNS;SLC36A4;SLC3A1;SFXN1;SLC25A38;SLC7A6;SLC1A4;SLC6A7;SLC25A12;SLC7A3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.24487810470878824,-0.7808382386193218,0.8220640569395018,0.9952084979292367,1.0,11/27,27.76%,RNF144A;TRAF6;RNF144B;DCUN1D3;PPARA;DCUN1D2;RNF180;SIAH2;FOXL2;RNF19B;DCUN1D4
prerank,ribosomal small subunit binding (GO:0043024),0.34538374213550493,0.7793969045622088,0.7218844984802432,0.9501352182688655,1.0,2/17,8.90%,CPEB2;EIF4B
prerank,pseudouridine synthase activity (GO:0009982),-0.30488846293655264,-0.7778895278083824,0.7640449438202247,0.9938507694578808,1.0,3/13,15.02%,PUS7;DKC1;RPUSD4
prerank,translation elongation factor activity (GO:0003746),0.35212048994969536,0.7778560246768049,0.7154088050314465,0.9500195995081531,1.0,1/14,2.89%,EEF1A1
prerank,Toll-like receptor binding (GO:0035325),-0.3289719387674369,-0.7772749669617198,0.7402597402597403,0.9888892678594049,1.0,3/11,13.65%,DAB2IP;TIRAP;UNC93B1
prerank,telomerase RNA binding (GO:0070034),0.33152396134635687,0.776179817634599,0.726027397260274,0.9501579724521863,1.0,4/22,13.84%,SNRPB;SMG7;GAR1;PINX1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3537249363778688,0.7731096304053338,0.7259036144578314,0.9522545081502587,1.0,4/14,14.80%,PYCR3;NOXRED1;ALDH1L2;ALDH1L1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3073861609597553,0.7707583132534434,0.7705146036161336,0.9533697568236095,1.0,5/27,14.06%,ITPR2;TMEM165;AQP1;SLC41A1;ATP2B4
prerank,GTP binding (GO:0005525),0.24938144012648447,0.7699324326840243,0.8468085106382979,0.9523367725631848,1.0,32/172,16.91%,MRAS;RAP1B;EEF1A1;RAP1A;ARL4A;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;ARF4;RHOU;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2
prerank,GTPase inhibitor activity (GO:0005095),0.3518265379067066,0.769574624266554,0.7416267942583732,0.9503984482132126,1.0,2/13,8.44%,CPEB2;IQGAP1
prerank,ribonuclease P activity (GO:0004526),0.37316812430076074,0.7693955233802022,0.7325769854132901,0.9482622141271867,1.0,3/11,12.35%,POP4;POP1;RPP21
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.22045073362568016,-0.7667304268265295,0.8678414096916299,0.9993735026217154,1.0,10/42,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,peptidoglycan binding (GO:0042834),0.3707811274477047,0.7667044947164745,0.7371048252911814,0.9497356827874556,1.0,4/10,19.32%,PGLYRP3;HK1;RNASE7;JCHAIN
prerank,single-stranded DNA binding (GO:0003697),0.2589489967422298,0.7654047775244892,0.8275862068965517,0.9493022300836709,1.0,28/93,22.45%,MLH1;SHOC1;POLR2H;NABP2;RNF138;CRY2;ERCC5;POLR3C;RPA3;REXO4;APTX;DHX9;MCM8;MCM6;POU4F1;SMC6;MCM7;PARK7;JCHAIN;PCBP2;NUCKS1;ERCC4;MAPT;NABP1;TWNK;MCM4;LONP1;IGHMBP2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.296514639020345,0.7653342725028501,0.7741935483870968,0.9470481747213482,1.0,11/35,25.83%,NT5C3A;LCMT2;TRPT1;TRIT1;AARS1;DUS2;GATB;DUS3L;FTO;TARS2;FTSJ1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2683473932429311,-0.7647527980780812,0.8172413793103448,0.9964098710779125,1.0,12/19,36.90%,WRNIP1;RFC3;HELQ;RAD51;RFC4;RFC2;DNA2;HELB;RFC5;DSCC1;CHTF18;PIF1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.31255271551679414,0.7578268397026544,0.768451519536903,0.9556651647992076,1.0,3/25,3.94%,ANXA8;PHLDA3;FCHSD2
prerank,cytokine receptor binding (GO:0005126),0.26230811276377475,0.7568884767753112,0.8260869565217391,0.9547284712738541,1.0,10/83,11.60%,CRLF1;CCL5;CLCF1;EPO;CCRL2;PXDN;TGFB2;VEGFB;SOCS2;JAK1
prerank,nucleosomal DNA binding (GO:0031492),0.31766193617469257,0.7530630201676902,0.78,0.9578930093503104,1.0,7/21,18.28%,SMARCB1;ACTB;SMARCA4;SMARCD2;GATAD2B;SMARCC1;H3-3A
prerank,peptide N-acetyltransferase activity (GO:0034212),0.36937850109196135,0.751310102553121,0.76592082616179,0.9580618760745215,1.0,3/10,13.91%,NAA15;NAA20;NAA10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.31949485626333674,-0.7511304448454165,0.7750611246943765,1.0,1.0,4/11,24.32%,PRMT3;PRMT9;PRMT6;CARM1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.31008929538090396,0.7499200248733943,0.7713884992987378,0.9576903194479335,1.0,3/24,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3076967960154588,-0.7497513865849725,0.8060941828254847,1.0,1.0,7/11,52.94%,CHRNB1;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,single-stranded RNA binding (GO:0003727),0.27921158192706097,0.7457108750183847,0.8025157232704403,0.9611079890762457,1.0,8/43,15.31%,STRBP;L1TD1;EIF4B;LACTB2;FXR1;ENDOV;ZFR2;DHX9
prerank,galactosyltransferase activity (GO:0008378),0.3467410955463291,0.7424464891570295,0.7572347266881029,0.9633105165006661,1.0,1/11,3.91%,A4GALT
prerank,endopeptidase regulator activity (GO:0061135),0.2804967701696327,0.7421628810634758,0.7798408488063661,0.9613341352027901,1.0,4/40,11.06%,SLPI;SPINT2;PSMF1;ABCA2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2505555837483991,-0.7393507813930993,0.8123076923076923,1.0,1.0,2/21,5.23%,KL;FGF2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2626391275714307,-0.7381426629072124,0.8374233128834356,1.0,1.0,4/16,12.25%,MTMR14;MTM1;MTMR7;MTMR2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2917913928736562,0.7376074838158841,0.8203017832647462,0.9651112754001905,1.0,4/33,9.40%,CNOT6;XRN2;EXOSC3;ERI3
prerank,DNA secondary structure binding (GO:0000217),0.29149861230696633,0.7373975440826575,0.7894002789400278,0.9630553459924064,1.0,10/31,23.67%,RECQL4;KMT2A;ERCC5;MEF2C;ABL1;LIN54;MAPT;YY1;MEN1;FANCM
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.2731735047197834,-0.7331080244329388,0.8126721763085399,1.0,1.0,5/15,14.80%,PIK3CB;PIK3CD;PIK3R3;PI4K2B;PIK3C3
prerank,wide pore channel activity (GO:0022829),0.30393946785181847,0.7323066360842795,0.7633477633477633,0.9677331638536455,1.0,2/23,5.31%,GJB6;GJC2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2513291096681705,0.7322422385938281,0.8499399759903962,0.9654686822150653,1.0,4/73,8.83%,SORCS2;CRHR2;LGR4;HCRTR1
prerank,gap junction channel activity (GO:0005243),0.30782160829576866,0.7314724816235006,0.7528901734104047,0.9642060965268989,1.0,2/22,5.31%,GJB6;GJC2
prerank,voltage-gated sodium channel activity (GO:0005248),0.302521350619596,0.7313945952834594,0.7742402315484804,0.9619682719799275,1.0,1/22,1.20%,SCN3A
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.32686781154678235,0.7313942192128594,0.7800312012480499,0.9573434245184855,1.0,5/16,18.84%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),0.32686781154678235,0.7313942192128594,0.7800312012480499,0.9573434245184855,1.0,5/16,18.84%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,carboxylic acid binding (GO:0031406),0.28184633105651324,0.7298518896970583,0.8143790849673203,0.9570295429473302,1.0,4/38,9.12%,RTN4R;SESN2;GLUD1;SHMT1
prerank,hormone activity (GO:0005179),0.2667170777873879,0.7297143639356096,0.835820895522388,0.9549182285695952,1.0,2/54,2.38%,GAL;PENK
prerank,methyl-CpG binding (GO:0008327),-0.2474628464586667,-0.7287932580646491,0.8549848942598187,1.0,1.0,7/22,24.47%,MBD2;MECP2;TET3;ZBTB21;MBD3;ZBTB33;ZBTB38
prerank,ion gated channel activity (GO:0022839),0.3062518041822823,0.7285792823279283,0.7877428998505231,0.9541232632919228,1.0,8/24,18.84%,ANO8;ANO7;TRPM4;PKD2L1;ANO6;ANO3;TMEM63B;TTYH3
prerank,copper ion binding (GO:0005507),-0.2096997559953952,-0.7283888488526372,0.8986784140969163,1.0,1.0,5/42,10.36%,PAM;MOXD1;ATOX1;LOXL3;TP53
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.28420567914277295,0.7267687548440694,0.815068493150685,0.9543301488377572,1.0,4/34,9.40%,CNOT6;XRN2;EXOSC3;ERI3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.31758972150927994,0.7248919468492327,0.7631578947368421,0.9545808814048478,1.0,4/15,22.75%,ABHD5;LPCAT2;ABHD4;GPAT3
prerank,transition metal ion binding (GO:0046914),0.22619999411364672,0.7229486109719593,0.9657258064516129,0.9548963341564706,1.0,87/397,22.21%,NAPEPLD;KLF4;FAM20C;MMP9;GPC1;MPPED2;FEN1;ADH7;TIMM10;EPRS1;ADAM33;GALNT1;HDAC4;LARGE1;TIMP1;RNF5;ALOX5;DUSP12;TIMP2;MGAT1;TES;KDM5C;KLF7;NQO2;TAB3;ANG;MSRB2;CHORDC1;CXXC4;FDX1;KMT2A;PITRM1;SHMT1;PHF5A;KDM3A;ZNF205;LACTB2;SOD2;HEPH;KDM4C;MYT1;PLSCR3;SCD5;MMP12;CHD3;ACO2;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;SNCB;MDM2;TET1;ABL1;SIAH1;SLC11A2;TAB2;ZFYVE1;PDXK;PCK2;USP16;PARK7;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ISCA2;ZBTB32;LVRN;TYW5;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;MELTF;ADPRM;DPF3;RASSF1;RCHY1;ARIH2;PHF2;XPNPEP1;AOX1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.260500921632559,-0.7205176717765648,0.8376068376068376,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,ephrin receptor activity (GO:0005003),-0.260500921632559,-0.7205176717765648,0.8376068376068376,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,aspartic-type peptidase activity (GO:0070001),0.35085847774817874,0.7201919088513278,0.7940691927512356,0.9560063724776,1.0,4/10,23.98%,NAPSA;BACE1;DDI2;PSEN1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.28594127064864616,-0.7198577488640575,0.8059299191374663,0.9999544785500557,1.0,2/12,5.29%,VEGFC;DAB2IP
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2507720016424353,0.7198395534628438,0.8598574821852731,0.9541803676478227,1.0,23/78,24.44%,USP46;USP29;USP10;CTSZ;CAPN2;GPAA1;CAPNS1;USP20;USP24;USP42;SFRP1;USP28;CTSH;USP25;USP16;CAPN15;CTSK;USP2;USP11;CASP3;USP13;USP34;CTSF
prerank,DNA polymerase binding (GO:0070182),0.3127019615072453,0.7101368396490719,0.8234421364985163,0.9642642789979946,1.0,6/18,21.78%,NABP2;SMARCA4;HSP90AA1;PCNA;PTGES3;LONP1
prerank,telomeric DNA binding (GO:0042162),0.27986431569390896,0.7067515721210051,0.8536912751677852,0.9662375785546278,1.0,15/32,31.44%,UPF3A;SMG7;HMBOX1;KDM1A;RAD50;TERF2;TINF2;APEX1;ZBTB48;XRCC5;TERT;TERF1;TERF2IP;NCL;TELO2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.25855481473544767,0.7059241122274627,0.8560975609756097,0.9649564306313562,1.0,14/49,23.59%,MPPED2;ATP1A2;DUSP10;DUSP12;PPP1CB;PGP;PLCXD3;DUSP11;DUSP3;ACP2;DUSP16;ACP6;ARMT1;APEX1
prerank,methylation-dependent protein binding (GO:0140034),-0.1917381218730173,-0.7056855389788904,0.9534883720930233,1.0,1.0,12/57,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.26446565463754756,-0.7036890350705601,0.8680981595092024,1.0,1.0,4/14,12.25%,MTMR14;MTM1;MTMR7;MTMR2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3377219407057072,0.7031777934305063,0.7911184210526315,0.9661413983849017,1.0,6/10,32.81%,FAN1;IDE;ANKRD13D;ANKRD13B;USP15;LAPTM5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2541260700661231,0.7014961830850857,0.8780788177339901,0.9658482051505547,1.0,9/55,14.06%,ITPR2;MCU;TMEM165;ANXA2;PKD1;PKD2L1;CACNB2;TRPM2;ATP2B4
prerank,3'-5' DNA helicase activity (GO:0043138),0.30655131362398286,0.6999103818344431,0.8272727272727273,0.9654709025848018,1.0,7/16,26.92%,RECQL4;DHX9;MCM6;MCM7;FANCM;FBH1;MCM2
prerank,cardiolipin binding (GO:1901612),0.34079527744976956,0.699580361228408,0.797945205479452,0.9636226335956398,1.0,3/10,19.86%,GSDME;OPA1;STOML2
prerank,acetyltransferase activity (GO:0016407),0.2818219642567417,0.698655592861222,0.8457223001402524,0.9625486172192982,1.0,5/31,13.91%,EP300;KAT6B;PAFAH2;NAA15;NAA10
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.24102168191411194,-0.6962469688200067,0.8960244648318043,1.0,1.0,8/20,23.81%,OTULINL;SENP2;SENP5;OTUB1;USP7;EIF3F;OTUD5;YOD1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2522393323703616,0.6961133755371678,0.8793103448275862,0.9634524674136409,1.0,10/60,12.89%,PPM1L;PPP2CA;PPM1B;DUSP1;UBLCP1;PP2D1;PPM1A;MTMR3;PPP1CB;PPM1D
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.26108951948964315,-0.6949852128018298,0.8719346049046321,1.0,1.0,4/14,25.53%,KCNJ2;KCNJ8;KCNIP2;KCNJ3
prerank,solute:sodium symporter activity (GO:0015370),-0.22421532798289828,-0.693860621696507,0.9207920792079208,1.0,1.0,6/27,24.65%,SLC4A10;SLC5A3;SLC5A11;SLC5A7;SLC4A8;SLC5A6
prerank,single-stranded telomeric DNA binding (GO:0043047),0.33239282006358695,0.6935887456624286,0.8065040650406504,0.9640935190653025,1.0,6/11,29.46%,NABP2;RAD50;TERF2;RPA2;TERF1;TERF2IP
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2186190222715574,-0.6934873836585471,0.9134948096885813,0.9959151140834825,1.0,8/29,19.24%,PRKAG2;PKIG;CIT;PRKAR2B;SPRED1;INCA1;PRKAR1B;CIB1
prerank,voltage-gated chloride channel activity (GO:0005247),0.3329358387833633,0.6916040129099799,0.7976973684210527,0.9642132622740208,1.0,2/10,12.23%,CLCN4;ANO6
prerank,ubiquitin binding (GO:0043130),0.23820468218764015,0.68621715658784,0.9039351851851852,0.9681690991396742,1.0,23/73,25.28%,CXCR4;HSPB1;NSFL1C;MARK4;UBXN7;NPLOC4;NEDD4;MDM2;IKBKG;RNF31;UBE2N;USP25;TSG101;USP16;RAE1;ILRUN;FBXW7;RNF168;DDI2;USP13;UBXN2A;NUP62;UBAP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.271660546213504,0.6850175710917072,0.8545454545454545,0.9673560983664904,1.0,3/28,9.39%,PRKAA2;AURKC;MAP2K2
prerank,SUMO binding (GO:0032183),-0.2612200320910796,-0.6843093113610933,0.8627450980392157,0.9995782656422674,1.0,4/13,17.50%,SERBP1;RNF4;SIMC1;USPL1
prerank,transcription corepressor binding (GO:0001222),0.27855575163501717,0.683807995846076,0.8406827880512091,0.9665037200465164,1.0,13/27,27.46%,ZBTB16;PHF1;LCOR;HDAC3;HDAC6;HDGF;ZBTB7A;USP11;PER1;PER2;WIZ;EHMT1;CTBP2
prerank,N-acetyltransferase activity (GO:0008080),0.2968390173238447,0.6820058001382474,0.8211624441132638,0.9662978381437137,1.0,3/19,13.91%,EP300;AANAT;NAA10
prerank,four-way junction DNA binding (GO:0000400),-0.248317140420354,-0.6797159679004389,0.9088319088319088,0.998632449631096,1.0,6/17,27.02%,RAD51D;HMGB1;BLM;XRCC2;RAD51B;GEN1
prerank,pyridoxal phosphate binding (GO:0030170),0.28655232426569505,0.6787180508182298,0.8628048780487805,0.9676551372820882,1.0,9/20,31.06%,ABAT;SHMT1;PDXK;PYGB;PYGM;PLPBP;PNPO;OAT;PSAT1
prerank,histone acetyltransferase binding (GO:0035035),0.28553115762204523,0.6784475181960872,0.8398133748055988,0.9657694950427005,1.0,5/21,19.55%,GLI3;FOXP3;BCAS3;PCNA;ZBTB7A
prerank,kinase activity (GO:0016301),0.22511247696286107,0.6766652161316162,0.9255555555555556,0.9654745297265704,1.0,23/109,17.85%,EPHA4;PIK3C2B;IP6K1;AGK;PMVK;STK39;MAPK15;NADK2;DCAKD;NADK;PPIP5K2;PI4KA;CKMT1A;DGKA;PKMYT1;PSTK;IRAK1;DOLK;GSK3B;IP6K2;ABL1;TRRAP;PDXK
prerank,triglyceride lipase activity (GO:0004806),0.28553627965962475,0.6757696144783295,0.8561354019746121,0.9642481028437561,1.0,1/20,3.17%,ABHD5
prerank,calcium-activated potassium channel activity (GO:0015269),-0.2728077311751354,-0.6755907783759533,0.8721804511278195,0.9972470394186238,1.0,3/11,15.22%,KCNN2;KCNMB4;KCNMA1
prerank,DNA replication origin binding (GO:0003688),0.27930308394189285,0.6742231759404748,0.8477011494252874,0.9637654900132022,1.0,7/23,21.59%,GRWD1;DHX9;MCM8;MCM6;MCM7;ORC2;MCM4
prerank,anion:anion antiporter activity (GO:0015301),0.2914264216269747,0.6727067129050375,0.8525835866261399,0.9631979898938235,1.0,6/17,25.00%,SLC4A2;SLC26A4;SLC25A4;SLC19A1;SLC25A11;SLC4A3
prerank,calcium activated cation channel activity (GO:0005227),0.29205599389946657,0.6717797028233992,0.8476190476190476,0.9619893712861124,1.0,7/17,22.93%,TRPM4;PKD2L1;ANO6;TMEM63B;KCNMB3;KCNMB2;ANO10
prerank,protein phosphatase regulator activity (GO:0019888),0.24128819324077044,0.6716575093048672,0.892059553349876,0.9599817144867703,1.0,14/53,19.17%,PPP6R3;RCAN1;PPP1R15A;PPP2R2D;LGALS3;LMTK2;PPP1R16A;PTN;SET;PPP1R1B;IGBP1;PPP2R2C;PPP2R5E;RCAN2
prerank,palmitoyltransferase activity (GO:0016409),0.26598665945007316,0.6689241583038198,0.859481582537517,0.9608388588747367,1.0,3/28,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.27492534051952905,-0.6679294696845555,0.8802083333333334,0.9987218132136333,1.0,8/11,53.74%,KCNJ8;KCNJ3;KCND3;KCNE5;KCNQ1;KCNJ5;KCNE2;KCNE3
prerank,channel activity (GO:0015267),-0.19234486533523604,-0.6677569679353454,0.9646017699115044,0.9934332099801934,1.0,12/41,28.35%,BCL2;PANX1;AQP11;AQP4;BAX;KCNK3;MPV17;CHRNB1;SLC14A1;TRPA1;TMEM120B;PANX2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3003933040881772,0.6677253622534134,0.8394863563402889,0.9599798436593756,1.0,2/14,9.99%,CMPK1;AK5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3271807185349147,0.667281424542608,0.8145800316957211,0.9583145263240574,1.0,1/11,6.74%,DDAH2
prerank,myosin V binding (GO:0031489),-0.25007007776200213,-0.6655850834118504,0.9028871391076115,0.990032285822954,1.0,4/15,19.53%,RAB11B;RAB39B;RAB3D;RAB3C
prerank,symporter activity (GO:0015293),-0.2752872541019813,-0.6564835897450731,0.8825,0.9927450561488043,1.0,3/10,24.65%,MFSD2A;SLC5A5;SLC5A6
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.24829761174093132,0.655112899765417,0.9158163265306123,0.9682858830501108,1.0,7/42,18.86%,CDKN1A;CCND2;CCND1;CCNL2;HEXIM1;CCNG1;CDKN2D
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.2430316283889838,-0.6545234027231285,0.8972222222222223,0.9889622286061371,1.0,1/14,1.56%,SLC26A7
prerank,phosphatidylglycerol binding (GO:1901611),0.30419118107661286,0.6539545161825412,0.8438003220611916,0.9672446773106221,1.0,3/13,12.69%,PITPNC1;GSDME;OPA1
prerank,protein phosphatase activator activity (GO:0072542),0.3018996034679077,0.6529989947495537,0.8768,0.9660414162583689,1.0,6/13,30.98%,PPP1R15A;PPP2R5E;CALM2;PHACTR4;CALM1;PPP2R5C
prerank,anion transmembrane transporter activity (GO:0008509),0.298613161606496,0.6508308183704629,0.8604269293924466,0.9658652345392754,1.0,1/12,2.52%,SLC4A2
prerank,MHC class I protein binding (GO:0042288),-0.25248689497127685,-0.6445785452848184,0.8871794871794871,0.9910441989407764,1.0,2/13,11.59%,TAP2;ATP5F1A
prerank,hormone receptor binding (GO:0051427),-0.24381771717932826,-0.6379583903158874,0.9102902374670184,0.9904131753353916,1.0,3/14,13.83%,JAK2;TYK2;PTHLH
prerank,phosphatase inhibitor activity (GO:0019212),0.2678755717518415,0.6370517473730379,0.8835820895522388,0.9763086887010013,1.0,5/20,15.09%,LGALS3;LMTK2;PTN;SET;PPP1R1B
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2300811219557729,0.6349556813937708,0.9274809160305344,0.9760846233628441,1.0,11/53,17.83%,MICAL2;CYB5R3;NQO2;ACADL;MICAL1;CRY2;ILVBL;SQLE;PPOX;KDM1A;PRODH
prerank,transaminase activity (GO:0008483),0.30364730684137947,0.6331636176201586,0.867330016583748,0.9754637698540617,1.0,2/11,16.10%,ABAT;BCAT2
prerank,metalloaminopeptidase activity (GO:0070006),-0.2262486724075324,-0.630364242922348,0.9322493224932249,0.990528523675819,1.0,5/16,23.20%,MMP16;ENPEP;ANPEP;XPNPEP3;TRHDE
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23411677571085368,0.6297999128280202,0.9230769230769231,0.9762683956847206,1.0,5/40,11.42%,CARNMT1;GAMT;NNMT;DNMT3A;THUMPD3
prerank,water transmembrane transporter activity (GO:0005372),0.2997580102016133,0.6294205703096093,0.8894230769230769,0.9745006946654212,1.0,2/11,12.79%,AQP1;PDPN
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.2495514880591293,0.6270335869769671,0.9162011173184358,0.9744811751648029,1.0,6/28,21.25%,EDA;FEM1B;PIDD1;TRIM37;TRAF4;TMBIM1
prerank,pentosyltransferase activity (GO:0016763),0.24037665352593074,0.6255169908696242,0.9295580110497238,0.9735502853574084,1.0,8/36,18.26%,LARGE1;PARP3;UPP2;UMPS;PARP6;TNKS2;UPP1;PARP2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.25224554529298715,-0.6243080080098888,0.9083333333333333,0.9894832128952609,1.0,5/11,27.37%,HMGA2;APLF;NEIL3;ALKBH1;NTHL1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.19636267222524725,-0.6235757015224871,0.9666666666666667,0.9848567119029509,1.0,12/29,27.43%,ACER2;GAA;GALC;GBA2;HPSE2;NEU1;CTBS;NEU3;HYAL2;ENGASE;OVGP1;HPSE
prerank,mannosyltransferase activity (GO:0000030),0.26763284607608495,0.6233920420012995,0.9120234604105572,0.9732254466532247,1.0,4/21,13.66%,TMTC1;PIGZ;ALG1;ALG12
prerank,RNA polymerase binding (GO:0070063),0.2648985133142211,0.6208561322482232,0.9059180576631259,0.9731894990544369,1.0,4/18,15.47%,STOM;NEDD4;DHX9;PABPN1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.23767287168344556,0.6178108530562868,0.9357045143638851,0.9734705460485177,1.0,10/34,21.77%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2F;UBE2J1;UBE2Z;UBE2E1
prerank,methylated histone binding (GO:0035064),-0.16326067446736064,-0.6173966330630458,0.9942857142857143,0.9837361392502484,1.0,12/62,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.2455266504703547,0.608589061882411,0.9318840579710145,0.9785205289583165,1.0,4/27,13.61%,ANKH;SLC22A8;SLC25A14;SLC26A4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.24046254391013017,-0.6084710915337196,0.9129411764705883,0.9838260210494371,1.0,2/12,12.35%,NOD1;RACK1
prerank,1-phosphatidylinositol binding (GO:0005545),0.27221665702538006,0.6070087770281056,0.9311475409836065,0.9776911452566961,1.0,6/15,26.40%,WDFY3;ZFYVE1;SESTD1;WDFY1;SNX10;EEA1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.26653275492661277,0.6066915058840372,0.9048316251830161,0.9758145479027279,1.0,1/18,2.60%,TNFAIP8
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2604384357058871,0.6052795679346766,0.913235294117647,0.9747801169844678,1.0,8/21,26.91%,EZR;AKAP5;WASF1;ARFGEF1;AKAP8;PRKACA;AKAP1;WASF3
prerank,NADPH binding (GO:0070402),0.2791944331351345,0.602320037464193,0.904833836858006,0.9746671849219335,1.0,2/13,14.28%,HMGCR;DUS2
prerank,zinc ion binding (GO:0008270),0.18957805474371506,0.5996094761893221,0.9979674796747967,0.9745018964475702,1.0,60/293,22.03%,NAPEPLD;KLF4;MMP9;ADH7;TIMM10;EPRS1;ADAM33;HDAC4;TIMP1;RNF5;DUSP12;TIMP2;TES;KDM5C;KLF7;NQO2;TAB3;MSRB2;CHORDC1;CXXC4;KMT2A;PITRM1;SHMT1;PHF5A;ZNF205;LACTB2;KDM4C;MYT1;MMP12;CHD3;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;MDM2;TET1;SIAH1;TAB2;ZFYVE1;PDXK;USP16;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ZBTB32;LVRN;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;DPF3;RASSF1;RCHY1;ARIH2;PHF2
prerank,RNA methyltransferase activity (GO:0008173),-0.21188993781010224,-0.5970965416430151,0.9444444444444444,0.9850196631876146,1.0,6/19,24.67%,METTL8;TRMT5;TRMT9B;TYW3;MRM2;BCDIN3D
prerank,cAMP response element binding (GO:0035497),0.2953271303612818,0.5958207346352669,0.8952536824877251,0.9750944378681137,1.0,4/10,18.46%,CREB1;JUN;CREB3L2;ATF2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.23012636966302366,0.5927678091480866,0.9443708609271523,0.9749731395659065,1.0,15/33,31.11%,RNF5;DCUN1D5;SIAH3;DCUN1D1;SIAH1;PARK7;ARIH2;RNF14;UBE3D;RPS3;RNF19A;UBA2;TOLLIP;PRKN;ARIH1
prerank,voltage-gated cation channel activity (GO:0022843),0.2001564058006271,0.5911679423826747,0.9809630459126539,0.9739514223113422,1.0,11/97,13.56%,CACNA2D3;CACNA1A;CACNB3;PTK2B;CACNA2D4;TMC2;KCNA4;KCNB1;KCNA5;CACNB2;KCNQ5
prerank,regulatory RNA binding (GO:0061980),0.22608013627840456,0.587108062654862,0.9567496723460026,0.9743904884621445,1.0,5/38,15.31%,ZC3H12A;TARBP2;TUT7;RBM10;DHX9
prerank,thioesterase binding (GO:0031996),-0.23826231222279498,-0.5849517816282669,0.9417249417249417,0.9858141906525509,1.0,4/11,21.99%,TRAF6;ARF6;TRAF1;HAUS7
prerank,MHC protein binding (GO:0042287),0.24525826967428008,0.5802455551741307,0.9390243902439024,0.9763354840447888,1.0,3/20,16.19%,CD81;ABCB9;ATP5F1B
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.22412765008784447,0.574070593237526,0.9578651685393258,0.9777735529849311,1.0,9/31,21.77%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2J1;UBE2Z;UBE2E1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.21522631608981263,-0.5696986235538359,0.9506849315068493,0.9873913120608203,1.0,4/14,23.65%,NOX4;NCF2;CYBB;AIFM1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.2181227988749581,0.5547086099265899,0.9565217391304348,0.9858590632882259,1.0,4/32,13.56%,KCNA4;KCNB1;KCNA5;KCNQ5
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.2111001612271698,0.5539088284601961,0.9677852348993289,0.9842018274778754,1.0,7/35,18.33%,PTK2B;CSK;STYK1;TXK;ABL1;PEAK1;YES1
prerank,peptide hormone receptor binding (GO:0051428),-0.2224733207784055,-0.5486133595778634,0.967479674796748,0.9903113360673101,1.0,11/11,77.77%,PTHLH;CCK;UCN2;GPHB5;GHRH;GPHA2;UCN3;PSMC5;GNRH1;VIP;ADCYAP1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2147450535650955,-0.5436082051332166,0.9556650246305419,0.9869607838203694,1.0,3/12,20.74%,TRAF6;BABAM2;TRAF1
prerank,O-methyltransferase activity (GO:0008171),0.2651435543218757,0.5419978079079202,0.9409780775716695,0.9875492932968053,1.0,4/10,25.57%,MEPCE;COQ3;CMTR2;LRTOMT
prerank,alpha-tubulin binding (GO:0043014),0.21038596663589293,0.5394304301944148,0.9688768606224628,0.9865183452134045,1.0,15/31,31.17%,EFHC2;WASHC1;ARL8A;HDAC6;TBCE;CDK5R1;TRPV4;ARL8B;FYN;RACGAP1;SNCA;TBCEL;EFHC1;TAOK1;ARL4C
prerank,ubiquitin-specific protease binding (GO:1990381),0.22970164077647218,0.5368208546809932,0.9578488372093024,0.9855371170229961,1.0,3/19,18.46%,LCOR;RHBDD2;PARK7
prerank,P-type ion transporter activity (GO:0015662),-0.20920523764260684,-0.532714662801148,0.9650872817955112,0.9852972968480029,1.0,1/12,3.59%,ATP2A2
prerank,aminopeptidase activity (GO:0004177),0.21091182305647083,0.5278251237322507,0.9786931818181818,0.9869093421081123,1.0,9/26,22.35%,NPEPPS;LTA4H;CTSH;LVRN;MMP14;RNPEPL1;METAP1D;XPNPEP1;BLMH
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.19528555341794002,-0.5227238815254482,0.9750692520775623,0.9831923469824224,1.0,4/15,21.94%,RBBP5;WDR5;PRDM9;WDR82
prerank,kinesin binding (GO:0019894),0.20973137869549566,0.5215220249539261,0.9740634005763689,0.9870213625023865,1.0,12/27,30.49%,KIF1B;ACTB;TOR1A;CROCC;AP1AR;KLC2;TTBK2;MAPK8IP1;SNCA;MAPK8IP2;AP1G1;SPAG9
prerank,miRNA binding (GO:0035198),0.1902674785171962,0.48333165434789827,0.9864130434782609,0.9959744233963264,1.0,3/30,13.19%,ZC3H12A;TUT7;RBM10
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18133261193205744,0.4533444624166103,0.994535519125683,0.9997067888705004,1.0,4/30,19.47%,TNFAIP8;CARD16;XIAP;UBE2Z
prerank,N-methyltransferase activity (GO:0008170),0.17290626445141505,0.4097492845660535,0.9924812030075187,1.0,1.0,7/20,26.21%,NNMT;PRMT1;ZCCHC4;FDXACB1;N6AMT1;TRMT11;METTL5
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.1539396565865379,0.35209360680247687,0.9984984984984985,1.0,1.0,1/16,6.48%,MACROD1
prerank,phospholipase binding (GO:0043274),0.16163179748863862,0.34699124889579464,1.0,1.0,1.0,5/13,30.84%,PAFAH1B1;FYN;PDPK1;PRKN;SYK
prerank,carbohydrate:cation symporter activity (GO:0005402),0.16566227244193332,0.3422009464426829,0.9967585089141004,0.9996241983745057,1.0,11/11,83.45%,SLC2A9;SLC2A10;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC17A5;SLC23A2;SLC23A1;SLC5A11;SLC5A3
